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ABSTRACT 
 
 
 
Interleukin-7 (IL-7) is a key cytokine in the development of B- and T-
lymphocytes. Responsiveness of lymphocyte populations to IL-7 is controlled by the 
temporal and cell specific expression of the IL-7 receptor (IL-7R). Although there are 
studies on the transcriptional regulation of IL-7R expression, these findings are 
insufficient to explain the tight regulation on IL-7R expression. 
 
In this study, we identified conserved upstream sequences at the mouse IL-7R 
alpha locus. We aligned murine and human genomic sequences using a pairwise global 
alignment approach and found seven noncoding genomic regions with more than 85 
percent conservation. We amplified the conserved sequences from a specific bacterial 
artificial chromosome and constructed luciferase reporter vectors representing these 
mouse genomic sequences. Here we investigate a reporter gene strategy to identify the 
transcriptional activation properties of these mouse sequences in a mouse T-lymphoma 
cell line.  
 
We evaluated the efficiency of luciferase assay system in a human kidney 
fibroblast cell line and a mouse CD4 single positive T-lymphocyte cell line. Due to the 
distinct expression properties of IL-7R, the present study can be expanded for cells 
representing the different stages of B- and T-lymphocyte development. Analysis of the 
transcriptional responses of different cell lineages to the conserved sequences will 
facilitate the studies on the investigation of the tight regulation on IL-7R expression. 
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ÖZET 
 
 
 
İnterlökin-7 (IL-7) B- ve T-lenfositlerin gelişiminde anahtar rol alan bir sitokindir. 
Lenfosit populasyonlarının IL-7'ye duyarlılığı, IL-7 reseptörünün (IL-7R) zamana ve 
hücre tipine bağlı ekspresyonu ile kontrol edilir. IL-7R geninin transkripsyonel kontrolü 
ile ilgili bir takım çalışmalar yapılmış olsa da, edinilen bulgular bu geninin üzerindeki 
sıkı kontrolü açıklamak için yeterli değildir. 
 
Bu çalışmada, fare IL-7R alfa lokusunda, transkripsyon başlangıç noktasından 
önde bulunan, korunmuş diziler aranmıştır. Fare ve insan genomunun bu bölgedeki 
dizileri ikili genel hizalama yöntemine göre karşılaştırılmış olup, yedi tane yüzde 85'in 
üzerinde korunmuş kodlamayan dizi bulunmuştur. Bu diziler polimeraz zincir 
reaksyonu ile, spesifik bakteriyel yapay kromozomundan çoğaltılıp lusiferaz haberci 
plazmidlerine klonlanmıştır. Klonlanan korunmuş dizilerin fare T-lenfoma 
hücrelerindeki transkripsyonel aktivasyon özelliklerini araştırmak için, lusiferaz genine 
dayanan bir genetik haberci stratejisi tasarlanmıştır. 
 
Belirlenen lusiferaz yöntemi, insan böbrek fibroblast hücrelerinde ve fare CD4 
pozitif T-lenfoma hücrelerinde denenmiştir. Bu çalışma, IL-7R geninin farklı 
ekspresyon özelliklerine dayanarak genişletilmelidir. B- ve T-lenfosit gelişiminin farklı 
evrelerindeki hücrelerin korunmuş dizilere olan transkripsyonel duyarlılıklarının 
incelenmesi, IL-7R geninin ekspresyonu üzerindeki kontrolü araştıran çalışmaları 
hızlandıracaktır. 
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1  INTRODUCTION 
1.1  Interleukin-7 Signalling 
Communication of immune cells is mediated by either cell-to-cell interactions or 
by local production of soluble factors. Cell-to-cell interactions involve molecules such 
as the T cell receptor (TCR), major histocompatibility complex (MHC), co-receptor 
molecules, integrins, accessory molecules and co-stimulatory molecules. On the other 
hand, cytokines are usually soluble, small-protein signalling molecules acting on cells at 
close proximity or on cells at a distance. Cytokines are a part of the extracellular 
signalling network that controls the development of immune cells, inflammation, 
defense against viruses and regulation of their own signalling. Receptors for cytokines 
are grouped into four families (Roitt et al., 2001).  The largest of the four families is the 
type I cytokine receptor family that contains the receptors for cytokines such as IL-2, 
IL-4 and IL-7 (Ozaki and Leonard, 2002). 
1.1.1  Interleukin-7 
Interleukin-7 (IL-7) is a critical cytokine in the survival and development of 
lymphocytes. IL-7 is a 25 kDa glycoprotein that is produced by stromal cells, 
monocytes, and some epithelial cells (Hofmeister et al., 1999). Stimulation of bone 
marrow precursor cells with cloned IL-7 gene identified IL-7 as a growth promoting 
factor (Namen et al., 1988). Later on, IL-7 or IL-7R deficient mice showed a severe 
reduction in the number of lymphocytes that denoted a major role to IL-7 in lymphoid 
development (Freeden-Jeffry et al., 1994; Peschon et al., 1994). Temporal expression of 
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the IL-7 receptor carefully controls the responsiveness of lymphoycte populations to IL-
7. As lymphocytes differentiate from bone marrow precursors to functional mature 
cells, they express the receptor for IL-7 at distinct stages, indicating that IL-7 survival 
signals are tightly regulated. This does not come as a surprise because misregulated 
survival signals can lead to the uncontrolled growth of lymphocytes. 
1.1.2  Interleukin-7 receptor 
IL-7 receptor is a heterodimer involving a common gamma chain (γc) and the IL-
7 receptor alpha chain (IL-7Rα or CD127). The common γc is shared by other cytokine 
receptors for IL-2, IL-4, IL-9, IL-15 and IL-21 (Ozaki and Leonard, 2002). It is shown 
that γc chain alone does not bind to IL-7 (Park et al., 1990). Also, it is demonstrated that 
IL-7 binds to IL-Rα and γc complex with a considerably higher affinity than IL-7Rα 
alone (Noguchi et al., 1993). In addition, chimeric receptor chains are created, which 
consist of the intracellular domains of IL-Rα or γc with the extracellular domain of an 
inducible receptor; and expression of a reporter gene flanking to a cytokine responsive 
promoter has been examined (Ziegler 1995). This study indicated that both chains are 
necessary for reporter gene expression. 
 
The IL-7Rα gene consists of eight exons and is found on chromosome 5 in human 
and chromosome 15 in mouse. IL-7Rα is particularly expressed on the cells in the 
lymphoid lineage. Common lymphoid progenitor cells (CLP) -which give rise to T, B 
and natural killer (NK) cells-, developing B- and T-lymphocytes, mature T cells, 
dendritic cell precursors and macrophages derived from bone marrow have been shown 
to express IL-7R (Figure 1.1). Furthermore, it is stated that, IL-7Rα is expressed on 
normal human intestinal epithelial cells, T cell lymphomas and several other 
nonlymphoid cancer cells and cell lines (Akashi et al., 1998; Cosenza et al., 2002). 
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Figure 1.1: Lineages of cells that differentiate from bone marrow precursors 
 
IL-7Rα consists of 439 amino acids and has a molecular weight 49.5 KDa. IL-
7Rα carries the characteristic features of type I cytokine receptor family members 
which all have two fibronectin-like domains, four conserved cysteine residues and a trp-
ser motif. It is a membrane glycoprotein with a single 25 aa transmembrane domain. 
The cytoplasmic domain of IL-7Rα contains a region with acidic residues (region-A), a 
serine rich region (region-S) and a region with three tyrosine residues (region-T) 
conserved between human and mouse (Jiang et al., 2005). Moreover, a cytoplasmic 
membrane-proximal domain named as Box1 is conserved among the type I cytokine 
receptor family (Murakami et al., 1991). IL-7Rα does not have a kinase domain and it 
is considered that A, S, T and Box1 regions contribute to the interactions with the 
intracellular adaptor and nonreceptor kinase molecules. 
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1.1.3  Interleukin-7 signalling pathways  
Signals from the IL-7 receptor are essential for lymphoid development and 
homeostasis.  In brief, IL-7 induces the heterodimerization of IL-7Rα and γc chains, a 
γc chain associated cytoplasmic kinase called JAK3 phosphorylates JAK1 that is bound 
to the α chain and the α chain itself, providing the accessibility of STAT transcription 
factors (Qin et al., 2001). Then, phosphorylated STATs dimerize and translocate into 
the nucleus resulting in the activation of cytokine specific genes (Foxwell et al., 1995). 
Furthermore, the activation of PI3 kinase has been found to be essential for the IL-7 
mediated survival and proliferation of human T cell precursors, indicating that JAK 
kinase activation of STAT transcription factors may not be the only downstream effects 
of IL7R signaling (Pallard et al., 1999). 
 
 
 
Figure 1.2: General representation of interleukin-7 activated signal transduction 
pathway (adapted from Kang and Der, 2004). 
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1.1.3.1  JAK/STAT pathway 
1.1.3.1.1  JAK3 
JAK3, which is a protein tyrosine kinase that is associated with the carboxy-
terminal region of γc, is accepted as the initial step in the signal transduction cascade 
from the IL-7 receptor. JAK3-deficient mice exhibit defects similar to the γc deficient 
mice. Mice with JAK3 deficiency show impaired lymphoid development which gives 
the evidence of the role of JAK3 in transducing the γc-dependent signals (Suzuki et al., 
2000). It is proposed that, JAK3 binds to γc by its amino-terminal region including two 
JAK homology domains (O’Shea et al., 2002). 
1.1.3.1.2  JAK1 
JAK1 is associated with the IL-7Rα chain and is activated by IL-7 induction. Jak1 
deficient mice showed impaired thymic development and gave no response to IL-7 
(Rodig et al., 1998), suggesting that this kinase is an essential component in IL-7 
signalling. Pyk2, a tyrosine kinase, has been shown to be linked with JAK1 and IL-7Rα. 
It is demonstrated that IL-7 induced the phosphorylation and enzymatic activity of Pyk2 
which has been shown to have a role in survival of a thymocyte cell line (Benbernou et 
al., 2000). Previously it was stated that, JAK1 interacts with IL-2Rβ chain resulting in 
the tyrosine phosphorylation of the p85 subunit of PI3 kinase (Migone et al., 1998). 
However IL-7 induced PI3 kinase activation of JAK1 has not been shown.  
1.1.3.1.3  STAT5a/b 
STAT family members of transcription factors are activated by a number of 
cytokine receptors. The SH2 domain of STAT5 docks to a phosphorylated tyrosine 
residue on IL-7Rα and phosphorylation of this SH2 domain makes dimerization of 
STAT5 possible. STAT5a and STAT5b are the two isoforms, which show 96% 
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sequence identity, can form homo or heterodimers upon phosphorylation induced by IL-
7 in T cells (Rosenthal et al., 1997). STAT5 is an anti-apoptotic transcription factor and 
it regulates the expression of many caspases and Bcl-2 family members (Debierre-
Grockiego, 2004). When STAT5a, STAT5b and combined STAT5a-b deficient mice 
were examined, these mice appeared to have impaired thymocyte development or 
deficiencies in the number of peripheral B and T cells (Teglund et al., 1998). This 
indicates that activation of STAT5 by IL7 signals plays a role in B and T cell 
development. Supporting this finding, it was found that phosphorylation of STAT5 was 
present in immature DN thymocytes, was downregulated in DP thymocytes and was 
reestablished gradually after positive selection (Van De Wiele et al., 2004). The 
development of T cells inside the thymus proceeds through a series of stages. The initial 
stage stands for CD3-CD4-CD8- double-negative (DN) immature thymocytes, followed 
by a CD4+CD8+ double-positive (DP) stage and, finally a single-positive (SP) stage 
containing CD4+ or CD8+ mature T cells (Fry and Mackall, 2002), (Figure 1.4). The 
presence of phospho-STAT5 exactly coincides with the presence of functional IL7 
receptor on the surface of these developing thymocytes, where DN thymocytes express 
surface IL7R, DP do not, and positively selected SP thymocytes re-express the IL7R. 
Furthermore, it is demonstrated that inhibition of STAT5b caused an increase in the 
number of DN thymocytes while the number of DP and γδ thymocytes decreased 
(Pallard et al., 1999). This finding indicates that IL7R is important in the differentiation 
of thymocytes beginning at a very early DN stage. 
 
The suppressor of cytokine signalling (SOCS) protein family members contain a 
characteristic SH2 domain which provides competition with STATs for binding to 
JAKs. It is shown that, T cells stimulated with IL-7 had an increased expression of 
SOCS1 (Starr and Hilton, 1998) and T cells of SOCS1 overexpressing mice were 
arrested at the DNI stage (Trop et al., 2001). Moreover, STAT5 activation is inhibited 
in SOCS1 transgenic mice (Fujimoto et al., 2000). These results indicate that there is a 
feed-back regulation in which IL-7 downregulates JAK1 activation by upregulating 
SOCS1. 
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1.2  Effects of Interleukin-7 signalling on B- and T-Lymphoid Cells 
B cell development proceeds in the bone marrow from a common lymphoid 
progenitor (CLP). CLP cells are characterized by the expression of IL-7Rα and c-kit 
which is the receptor for stem cell factor (SCF). Expression of the surface marker, B220 
and low levels of heat stable antigen (HSA) is the marker for the pre-pro-B cell which is 
the first identifiable progenitor committed to the B lineage (Figure 1.3). A period of 
proliferation and beginning of immunoglobulin heavy chain rearrangement take place 
during the transition to the pro-Bcell stage. At the early pre-B-cell stage, heavy chain 
rearrangement is completed and successfully rearranged cells expand in response to IL-
7 and other factors. At the late pre-B-cell stage, IL-7Rα expression disappears and is no 
longer observed on B cells at later stages (Fry and Mackall, 2002). 
 
 
 
Figure 1.3: B-cell development in relation to IL-7Rα expression and IL-7 
responsiveness (adapted from Fry and Mackall, 2002). 
 
Signals from IL-7 receptor are required for B-cell development in mice. It is 
observed that in IL-7 deficient mice, transition from pro-B-cell stage to pre-B-cell stage 
is blocked (von Freeden-Jeffry et al., 1995). On the other hand, in IL-7R deficient mice, 
the block in B-cell development occurred earlier, at the pre-pro-B-cell stage. (Peschon 
et al., 1994) This is explained by the presence of a second molecule named as Thymic 
stromal lymphopoietin (TSLP) that also uses IL-7Rα to signal and compensates the loss 
of IL-7 up to a level at the pre–pro–B-cell stage (Ray et al., 1996) In addition to these 
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findings, pre-pro-B cell growth-stimulating factor (PPBSF), which is a heterodimer of 
IL-7 and the variant β-chain of hepatocyte growth factor is demonstrated to stimulate 
proliferation and differentiation in vitro (Mckenna et al., 1998).  
 
More recently, it was proposed that IL-7 regulated the chromosome accessibility 
of immunoglobulin heavy chain (IgH) locus in pro-B-cells. It is observed that IL-7 
induces hyperacetylation of histones and therefore promotes the nuclease accessibility 
of the largest family of VH genes and activates these segments for potential 
recombination by RAG (Chowdhury and Sen, 2001). Compared to pro-B-cells, 
Chowdhury and colleagues found decreased IL-7R expression and lower levels of 
activated STAT5 in pre-B-cells. Moreover, they demonstrated that the termination of 
IL-7 signalling promoted allelic exclusion at certain VH gene segments in pre-B-cells 
(Chowdhury and Sen, 2003). These studies also showed the recombinational 
reactivation of VH genes with exogenous IL-7 in mature B cells whose VH genes have 
already been allelically excluded.  
 
IL-7 signalling also promotes VDJ recombination at the TCRγ locus in mice. 
Rearrangement of the TCRγ locus is severely repressed in IL-7Rα deficient mice (Maki 
et al., 1996). Later on, it was shown that STAT5 overexpression in IL-7R deficient 
thymocyte precursors resulted in increased levels of acetylated histones associated with 
the TCRγ locus and unrearranged germline transcripts which are the indicators of TCRγ 
locus accessibility. Furthermore, mice deficient in IL-7 showed partially restored γδ 
thymocyte development in response to STAT5 expression (Ye et al., 2001), which 
suggests that STAT5 has a role in controlling the TCRγ locus accessibility. 
 
CLP stage is the first stage that expression of IL-7Rα can be detected. During 
thymocyte development IL-7Rα levels are tightly regulated. While high levels of 
expression is found on DN thymocytes, DP cells do not express detectable amount of 
IL-7R (Figure 1.4). In later stages, mature SP cells and peripheral T cells express higher 
levels of IL-7R on their surface (Munitic et al., 2004). The development of T cells 
inside the thymus proceeds through a series of stages. The first stage stands for CD3-
CD4-CD8- double-negative (DN) immature thymocytes, followed by a CD4+CD8+ 
double-positive (DP) stage and, finally a single-positive (SP) stage containing CD4+ or 
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CD8+ mature T cells. The DN, DP, and SP stages respectively represent 5%, 80%, and 
15% of the thymocyte pool (Fry and Mackall, 2002).  Investigations on IL-7 (Moore et 
al., 1996) and IL-7Rα (Peschon et al., 1994) deficient mice revealed that thymic 
cellularity is more severely reduced in IL-7Rα deficient mice and the differentiation of 
DN thymocytes is only partially inhibited in IL-7 deficient mice compared to IL-7Rα 
deficient mice. The reason for that is explained by the importance of TSLP as in the B 
cell development. 
 
IL-7 signalling maintains the survival and expansion of DN thymocytes by 
upregulating bcl-2 family members. It is stated that double negative DNII (Figure 1.4) 
cells purified from IL-7 deficient mice have increased apoptosis and decreased levels of 
bcl2 gene expression (von Freeden-Jeffry et al., 1997) In addition, forced expression of 
bcl-2 transgene in IL-7Rα deficient mice caused an increased number of thymocytes 
and the alleviation of some of the defects of IL7R deficiency (Maraskovsky et al.,1997). 
 
 
 
Figure 1.4: Developmental stages and IL-7Rα expression of T-lymphocytes (adapted 
from Fry and Mackall, 2002). 
 
In a series of experiments, IL-7Rα transgenic mice were used to explain the loss 
of IL-7Rα expression in normal DP thymocytes. TCF-1, LEF-1, and RORγt 
transcription factors that promote the transition into the DP stage were downregulated in 
IL-7Rα transgenic mice, suggesting that IL-7R downregulation is required for transition 
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into DP stage (Yu et al., 2004).  In IL7R transgenic mice, antigen specific negative 
selection at DP stage was found to be unaffected by the continuous expression of IL-
7Rα, however it was demonstrated that number of thymocytes greatly reduced 
depending on age. This result is explained by the fact that expanding DP thymocytes 
which express IL-7Rα on their surface decreased the availability of IL-7 to DN cells in 
thymus due to competition (Munitic et al., 2004). Therefore, tight regulation of IL-7Rα 
is crucial to maintain essential IL-7 levels for the precursor DN cells. 
 
IL-7 is strictly required for co-receptor reversal at the transition from CD4+CD8- 
intermediate stage into CD4-CD8+ SP stage. DP thymocytes have the potency to 
become either CD4+ or CD8+ single positive cells (Figure 1.4). According to the co-
receptor reversal model of thymocyte development, CD4+CD8+ DP thymocytes cease 
CD8 expression and become CD4+CD8- intermediate thymocytes. At this intermediate 
stage, if TCR signals are sustained, cells differentiate into CD+4 SP cells; otherwise 
cells turn into CD8+ SP cells (Singer, 2002).  Recently, the significance of cytokine 
signalling in co-receptor reversal has been demonstrated by showing that IL-7 receptor 
signals are required for up-regulation of Bcl-2 gene expression to maintain thymocyte 
viability, enhancement of CD4 gene silencing, up-regulation of glucose transporters on 
the cell surface and also for functional maturation of intermediate thymocytes into CD8+ 
SP T cells (Yu et al., 2003). 
 
In peripheral organs, naïve T cells require survival signals from TCR-MHC-
peptide interactions and from IL-7 receptor. High levels of IL-7R expression is 
observed in naïve CD4+ SP and CD8+ SP T cells. Besides the survival function, IL-7 
signals are required for homeostasis of naïve T cell population meaning that number of 
peripheral naïve T cells is under control. Upon antigen stimulation, T cells turn into 
activated effector cells and IL-7R expression is reduced. At the same time, expression 
of other cytokine receptors such as IL-2, IL-4 and IL-15 is upregulated which are 
responsible for differentiation and expansion of effector T cells. After the elimination of 
antigen, memory T cells are formed and IL-7R expression is upregulated again. IL-7 
signals induce survival and maintain homeostatic turnover of memory T cells (Bradley 
et al., 2005). 
 11 
1.3  Regulation of IL-7 Receptor-α Gene 
As mentioned in the previous chapter, development of B- and T-lymphocytes 
proceeds through a series of stages. These stages of lymphocytes differ from each other 
by chromosomal rearrangement status and surface expression of characteristic proteins. 
For example, IL-7 signalling is essential for the survival of B-lymphocytes at early 
stages of development (Figure 1.3). But the cells at the pre-B-cell stage loose their 
responsiveness to IL-7 signalling as a result of disappearing of IL7-R expression on 
their surfaces. Moreover, during T-lymphocyte development, IL-7R expression is 
missing at certain stages (Figure 1.4).  
 
The influence of IL-7 signalling on lymphoid cells can not be explained by IL-7 
due to the fact that the regulation of IL-7 production is poorly understood (Alpdogan 
and van den Brink, 2005). In fact, which lymphoycte population is responsive to IL7 is 
carefully controlled by the temporal expression of the IL7 receptor. This indicates the 
presence of a tight regulation on IL-7R gene expression at distinct stages of lymphocyte 
development. 
 
An ETS family transcription factor, PU.1 has been shown to control IL-7R 
expression in early B cell progenitors. Two PU.1 binding sites have been identified at 
the IL-7R gene locus. It is shown that PU.1 defective lymphoid progenitor cells failed to 
express IL-7Rα gene (DeKoter et al., 2002). PU.1 is not expressed after lymphoid 
progenitors are fully committed to the T cell lineage. Furthermore, a GGAA binding 
protein (GABP) is identified to bind the PU.1 binding motif in T cells (Xue et al., 
2004). However, these findings were not sufficient to clarify the mechanism for the 
tight regulation of IL-7R expression at distinct T-lymphocyte stages.  
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1.4  Influence of Cis-regulatory Regions on Gene Transcription 
Complexity of organisms is mostly referred to complexity and organization of 
gene expression rather than gene number. Temporal and spatial patterns of gene 
expression, variable alternative splicing and stability of mRNAs, post-translational 
modification and differential targeting of proteins are some considerations that reflect 
the complexity of organisms. Transcriptional initiation requires binding of specific 
proteins to promoter sequences as well as to a variety of regulatory elements frequently 
located far from the transcription initiation site. These regulatory regions often contain 
multiple copies of protein binding sites (Rutherford, 2000). Nardone and colleagues 
summarize these findings by stating that “The modular architecture of proteins and 
DNA is likely to be responsible for the complexity, versatility, flexibility and robustness 
of organisms and for their continued ability to evolve and adapt” (Nardone et al., 2004).  
 
Achievements in genome sequencing in recent years allowed comparative 
sequence analysis of vertebrate genomes (Nardone et al., 2004). Results of 
bioinformatic studies and biological analyses showed that conserved noncoding 
sequences (CNS) are where transcriptional cis-regulatory elements reside in the 
genome. These cis-regulatory elements may be situated either upstream or downstream 
of the regulated gene. Although the size of cis regulatory sequences can be only a few 
hundred basepairs, these regulatory elements may be located at tens to hundreds of 
kilobases away from the transcriptional start site (Mortlock et al., 2003).  
  
Functional conservation of regulatory elements between species and reflection of 
this conservation into DNA sequences are the assumptions for utilizing comparative 
bioinformatic tools. Several comparative genomics programs are available online. 
AVID is a global alignment program (Bray et al,. 2003) available in the VISTA web 
site (www-gsd.lbl.gov/vista/) (Mayor et al., 2000). Global alignment programs generate 
a single alignment across the entire length of two sequences. On the other hand, local 
alignment programs such as BLASTZ that is available in PipMaker web site 
(http://pipmaker.bx.psu.edu/pipmaker), find short high-quality alignments between two 
sequences. When using AVID-VISTA, a few parameters are required for the alignment. 
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Window length and minimum similarity to be visualized are set by the user. Setting a 
large window length may ignore some short CNSs. Conversely, smaller window lengths 
may cause higher background. 
 
Genomic comparison of closely related species (e.g. mouse and rat) often gives a 
high degree of similarity. On the other hand, choosing very distant organisms (e.g. 
chicken and human) will result in only a few highly conserved sequences. The optimal 
way is comparing moderately related organisms such as mouse and human depending 
on the purpose. In addition, comparison of multiple species increases the power of the 
technique, further refining the boundaries of CNS regions (Thomas et al., 2003). 
 
As mentioned above, comparative softwares are valuable tools for identifying 
CNSs. The exact function of these conserved elements can be evaluated and verified by 
biological experiments. DNase I hypersensitivity assay, targeted disruption of putative 
regulatory sequences, chromatin immunoprecipitation, gel mobility shift assay and a 
variety reporter gene assays are some of the methods often used for identifying 
functional regulatory sequences (Nardone et al., 2004). 
1.5  Reporter Genes 
In recent years chemi- and bioluminescence measurements have become 
extremely popular and been used to determine the amount of a specific unknown in a 
sample. Experimentally, the amount of light output is proportional to the amount of the 
luminescent material in the sample of interest. Chemiluminescence is the light emission 
upon a chemical reaction. Similarly, bioluminescence is a type of chemiluminescence in 
which an enzyme catalyzes the chemical reaction that emits light (Kricka, 1995). More 
recently, bioluminescence methods have become very important tools for gene 
expression and gene regulation studies (Wood, 2004).  
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1.5.1  Luciferases 
Enzymes that catalyze a reaction yielding visible light are called luciferases as a 
generic term. The reaction involves the formation of an electronically excited 
intermediate and return of it to the ground state resulting in the emission of a photon 
light. Luciferases catalyze the oxygenation of substrates known as luciferins, creating 
high energy peroxidic intermediates. These intermediates spontaneously decompose and 
generate electronically excited products that emit a photon in the range of visible light 
upon decaying (Wilson and Hastings, 1998). In the case of firefly luciferase (an enzyme 
cloned from the Photinus pyralis species of fireflies), this return to the ground state 
results in the emission of a yellow-green light at the wavelength of  562–570 nm with 
maximum intensity (Shimomura et al., 1977). 
 
The structure of Luciferase enzymes are diverse among different organisms. 
These enzymes catalyze diverse reactions and use a wide range of substrates. However, 
involvement of oxygen is common for all luciferase reactions (Hastings, 1983). The 
emission of light occurs by different molecular mechanisms in different luciferase 
enzymes. Therefore, it is thought that rather than evolve from a common ancestoral 
enzyme, current day luciferases evolved independently in different species (Wilson and 
Hastings, 1998). For example, luciferase cDNA cloned from the dinoflagellate, 
Gonyaulax polyedra, does not show any sequence similarities to other luciferases in 
databases (Li et al., 1997). 
 
Among the bioluminescent organisms, insects are the most diverse group. 
Currently ~2500 species are described to have luminescence (Viviani, 2002). 
Collembola (springtails), Diptera (flies), and Coleoptera (beetles) have been shown to 
have luminescence (Herring, 1978). Except the firefly luciferases, which have been 
extensively studied, the mechanisms and properties of many insect luciferases are still 
poorly characterized. The firefly luciferase is the most studied and best characterized 
model among other insect luciferases (Viviani, 2002). Between 1950s and the 1980s, 
biochemical studies required collecting samples from natural firefly collectors. 
However, cloning of the luciferase cDNA from the North American firefly, Photinus 
pyralis, and expression of the gene in E.coli provided an alternative source of the 
enzyme (De Wet et al., 1985). Later on, many laboratory organisms around the world 
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have been transfected and as a consequence of expression of the firefly luciferase, they 
began to emit the specific yellow-green luminescence (Baldwin, 1996). 
1.5.1.1  Firefly luciferase reaction 
Photinus pyralis luciferase, which has a molecular weight of 62 kDa, requires 
ATP, O2 and luciferin as substrates (Figure1.5). In the first reaction enzyme-luciferyl 
adenylate complex is formed. In the second reaction, CO2, AMP, oxyluciferin and light 
is produced as a result of an oxidative decarboxylation of lucyferyl adenylate complex 
(De Wet et al., 1987). Figure 1.6 shows the chemical structure of beetle luciferin and 
the bioluminescent reaction catalyzed by firefly luciferase. In case of excess substrates, 
a flash of light is produced that is proportional to the quantity of enzyme in the reaction. 
 
  
 
Figure 1.5: Reaction catalyzed by firefly luciferase. 
 
 
 
Figure 1.6: Chemical structure of beetle luciferin and bioluminescent reaction catalyzed 
by firefly luciferase. 
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1.5.2  Reporter gene systems 
Genetic reporters are widely used in cell biology to study gene expression. It is 
also possible to study cellular events such as receptor activity, signal transduction and 
protein interactions which are coupled to gene expression (Ausubel et al., 2002). 
Reporter vectors usually consist of a reporter gene encoding for a protein whose 
presence or activity due to expression can be detectible. A promoter activator binding 
site or an enhancer sequence under interest can be inserted into the multiple cloning site 
of a reporter vector. Analysis of the reporter gene expression indicates the transcription 
promoting ability of the sequence under interest. Commonly, reporter vectors are 
transiently transfected; however expression of the reporter protein should not have any 
effects on physiology of the host cell and show no toxicity. Moreover, in a good 
reporter system, the expression or activity of the reporter molecule should be sensitively 
detectible. Many systems provide measurement within several logs of activity (Alam 
and Cook, 1990). 
 
Expression of most eukaryotic genes is controlled by complex regulational 
mechanisms. Cis-acting sequences and trans-acting elements have a major role in 
recruiting certain transcription activators which specifically recognize these sequences. 
Specific binding of transcription factors to promoter or enhancer elements which are 
generally found upstream of genes mediate the initiation of transcription. Direct 
methods for expression analysis involve the measurement of mRNA synthesized using 
northern blots or similar techniques. Such techniques are often labor intensive and time 
consuming compared to reporter systems (Ausubel et al., 2002). 
1.5.2.1  Reporter genes other than luciferase 
In vitro reporter systems can either use isotopic or nonisotopic methods.  Isotopic 
assays for reporter gene activity involves the chloramphenicol acetyltransferase (CAT) 
and human growth hormone (hGH) reporter systems. CAT is a prokaryotic enzyme 
which catalyzes the transfer of acetyl groups from acetyl-coenzyme A to 
chloramphenicol. Lysates of the cells that are transiently transfected with CAT vectors 
are incubated with [C14]chloramphenicol. Acetylated and unacetylated chloramphenicol 
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molecules are separated by thin layer chromatography for qualitatively estimating the 
CAT activity on X-ray films (Glover, 1985). CAT assay has very low signal-to-noise 
ratios due to low competing activities of the prokaryotic CAT enzyme with most 
eukaryotic cells. However, CAT assays are time consuming and require radioactive 
substrates which are relatively expensive and have hazardous risk. In addition, CAT 
assays have lower sensitivity compared to nonisotopic methods that have been recently 
developed (Ausubel et al., 2002). hGH is another isotopic genetic reporter which is 
normally secreted from the somatotrophic cells in the anterior pituitary gland. Common 
use of hGH as a reporter gene is for normalizing the transfection efficiency as an 
internal control (Selden et al., 1986). However, hGH requires hazardous 
radioimmunoassay for quantitation and has relatively low sensitivity than the other 
secreted reporter protein SEAP. 
 
Nonisotopic assays for reporter gene activity involves the β-galactosidase, β-
glucuronidase (GUS), secreted alkaline phosphatase (SEAP) and firefly luciferase 
reporter assays. β-galactosidase is one of the most widely used in vitro and in vivo 
genetic reporters. The β-galactosidase enzyme which is encoded by E.coli lacZ gene 
catalyzes the hydrolysis of several β-galactosides. X-gal, 5-bromo-4-chloro-3-indolyl-β-
D-galactoside is the most commonly used substrate for reporter assays (Fowler and 
Zabin, 1983). In addition to being a reporter gene alone, β-galactoside is commonly 
used as a normalizing factor when expressed in cells together with the luciferase gene 
(Martin et al., 1996). Similar to β-galactosidase, principle of GUS assays is the 
hydrolysis of various β-glucuronides. GUS reporter gene is very commonly used to 
study gene expression in plants due to low endogenous GUS expression in most plants 
compared to mammalian cells (Bronstein et al., 1994). Another reporter gene SEAP is a 
form of human placental alkaline phosphatase gene but lacks the membrane anchorage 
domain. Different from other reporter genes, SEAP is secreted to the medium. This 
property of SEAP allows performing the assays without disruption of the cells and gene 
expression kinetics can be studied. However, SEAP reporter assay has a narrow 
dynamic range and low sensitivity than other commonly used assays. To overcome 
these disadvantages, there are some modification and enhancement studies for this 
method such as two step SEAP assay which utilizes a substrate that is linked to 
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luciferin. In the second step, released luciferin serves as the substrate for firefly 
luciferase which has a greater sensitivity (Berger et al., 1988). 
1.5.2.2  Luciferase reporter gene system 
Cloning of the luciferase gene from Photinus pyralis created a nonisotopic genetic 
reporter system (De Wet et al., 1985). Firefly luciferase requires ATP, Mg2+, O2 and 
luciferin to catalyze a bioluminescent reaction. Luciferase protein has a half life of three 
hours in cultured cells due to its sensitivity to degradation by proteases. The short half 
life in the cytoplasm makes of the luciferase protein suitable for studying inducible 
systems. Reaction of luciferase with the substrates generates a flash of light which 
decays rapidly in one second. Therefore a luminometer equipped with an autoinjection 
device is required. The detected light is presumed to be an indirect estimate of luciferase 
gene transcription. Although luciferase produces a flash of light in the classical method 
addition of Coenzyme-A in the reaction mixture increases the duration of signal nearly 
constant up to one minute due to favorable interaction of luciferase with luciferyl- CoA 
that eliminates the need for a luminometer with an autoinjection device (Wood, 2004).  
 
Measurement of luminescence is performed by photomultiplier tubes (PMTs) that 
are the photon detection devices commonly found in luminometers (Turner, 1985). 
Luminometers are either current-measuring or photon-counting according to their 
processing of the luminescent signal. A current-measuring luminometer measures the 
signal in a way that it produces an electrical current due to striking of the photons to the 
PMT. On the other hand, a photon-counting luminometer counts each photon that reach 
to the PMT. Photon-counting luminometers show a great sensitivity therefore very low 
levels of light can be detected. However these instruments have a limited dynamic range 
compared to current-measuring luminometers. While low light levels can be measured 
sensitively, at high levels of luminescence, the instrument is saturated which makes the 
linear range of detection narrower. On the other hand, there are difficulties with current 
producing luminometers in that low levels of light is hard to be detected sensitively and 
consistency is lost. Indeed, lower limit of detection of current producing luminometers 
may be undesirably high compared to photon-counting luminometers (Wampler, 1985).  
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Firefly luciferase as a reporter protein can be measured with a very broad linearity 
and with very high sensitivity, down to just femtogram levels in a sample. Using a 
single reporter in an assay is a quick way of acquiring data for gene expression in cells. 
However, cells have complex physiology and therefore data acquired from a single 
reporter assay may not be reliable all the time. So, dual assays are developed which 
improved the reliability of experimental results (Wood, 2004). Significant variability 
lowers the reproducibility between samples in an experiment due to the complex nature 
of cells. In addition, variability may come from instrumental reasons due to static 
electricity and humidity across the plate (Faridi et al., 2003). To overcome these 
undesired variables, dual assays are used which leads to more accurate comparisons 
between samples. Moreover, cytotoxicity of the reporter protein may cause down 
regulation of expression. Using a dual assay allows the normalization of the 
measurement of reporter gene activity independent of cell physiology and call viability 
(Hirose et al., 2002).  
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2  PURPOSE OF THE STUDY 
As mentioned in the Introduction, lymphoid development proceeds through a 
series of stages in which the bone marrow precursors differentiate into functional 
lymphocytes. IL-7 is a critical cytokine for both developing and mature lymphocytes. It 
provides survival and proliferation signals whose loss can not be compensated by other 
cytokines and misregulated survival signals can lead to the uncontrolled growth of 
lymphocytes. At some stages of development, lymphocytes are responsive to IL-7 
signals and at some stages, they are not. Responsiveness of cells to IL-7 is strictly 
controlled by the regulated expression of IL-7 receptor. Studies for explaining the tight 
control on IL-7R expression revealed that a number of transcription factors have the 
ability to bind IL-7R promoter region. However, these findings are still insufficient to 
clarify the temporal and cell specific surface expression of IL-7 receptor.  
 
In this study, we aimed to evaluate the possible role of upstream conserved 
noncoding sequences in the expression of IL-7R gene. For this reason, we determined 
several conserved sequences by the comparative analysis between mouse and human 
genomic sequences. To investigate the transcriptional activation capabilities of these 
sequences, we cloned them into luciferase reporter gene plasmids for further 
transfections and reporter assays. An IL-7R+ mouse CD4+ T-lymphoma cell line was 
selected to examine the transcriptional activities of cloned sequences. 
 
Details of identification and cloning of upstream conserved sequences are 
presented in this thesis together with the luciferase reporter assays performed with a T-
lymphoid and a non-lymphoid cell line. Next steps involve the examination of cloned 
sequences with different cell lines which represent the distinct developmental stages of 
lymphocyte development by using fluorescent protein reporter systems. Identifying an 
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enhancer region acting on IL-7R gene expression will contribute to the understanding of 
IL-7 signalling in lymphocyte development. 
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3  MATERIALS AND METHODS 
3.1  Materials 
3.1.1  Chemicals 
Chemicals used in the study are listed in Appendix A. 
3.1.2  Molecular Biology Kits 
Molecular biology kits used in the study are listed in Appendix B. 
3.1.3  Equipment 
 Equipment used in the study is listed in Appendix C. 
3.1.4  Enzymes 
 Enzymes and their reaction buffers that are used in restriction digestion, 
amplification, ligation and other processes are listed in Appendix D. 
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3.1.5  Plasmids, cells, oligonucleotides and molecular weight markers 
Plasmids, cells, oligonucleotides and DNA markers that are used in the study are 
listed in Appendix E. Maps of plasmids that are used and constructed are given in 
Appendix F.  
3.1.6  Softwares and online programs 
AVID-VISTA   http://www-gsd.lbl.gov/vista 
Primer3   http://frodo.wi.mit.edu/primer3 
SoftMax Pro4.3  Molecular Devices Inc., USA 
Spidey    http://www.ncbi.nlm.nih.gov/IEB/Research/Ostell/Spidey 
UCSC Genome Browser http://www.genome.ucsc.edu 
VectorNTI 9.1.0  Invitrogen, USA 
3.1.7  Growth media 
3.1.7.1  Bacterial growth media 
3.1.7.1.1  Solid media 
40 g of Luria Agar was dissolved in 1 L of distilled water and autoclaved at 121°C 
for 15 minutes. If necessary, ampicillin or kanamycin at a final concentration of 100 
µg/ml; or chloroamphenicol at a final concentration of 12.5 µg/ml were added into the 
medium for selection. Then, approximately 15 ml of the medium was poured into each 
sterile Petri plate. 
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3.1.7.1.2  Liquid media 
20 g of Luria Broth was dissolved in 1 L of distilled water and autoclaved at 
121°C for 15 minutes. If necessary, appropriate antibiotics were added into the liquid 
medium for selection.  
 
3.1.7.2  Mammalian growth media 
3.1.7.2.1  Growth media for adherent cells 
293T human kidney fibroblast cell line was grown in Dulbecco’s Modified Eagle 
Medium (DMEM) culture medium which was supplemented with 10% fetal bovine 
serum, 2 mM L-glutamine, 10% fetal bovine serum, 100 unit/ml penicillin and 100 
unit/ml streptomycin.  
3.1.7.2.2  Growth media for suspension cells 
EL4 mouse T-lymphoma cells were grown in RPMI 1640 cell culture medium 
which was supplemented with 5 % fetal bovine serum, 2 mM L-glutamine, 100 unit/ml 
penicillin and 100 unit/ml streptomycin.  
3.1.7.2.3  Freezing medium 
DMSO was added into fetal bovine serum at a concentration of 10% v/v and stored at 
4°C.Freezing medium 
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3.1.8  Buffers and solutions 
Standard buffers and solutions used in the study were prepared according to the 
protocols in Sambrook et al., 2001. 
 
- 5X Tris-Borate-EDTA (TBE) Buffer: 54 g Tris base, 27.5 g boric acid and 20 ml 
0.5 M EDTA at pH 8.0 were dissolved in 1 L of distilled H2O.  
 
- Agarose gel: For 1% w/v agarose gel preparation, 1 g of agarose was dissolved 
in 100 ml 0.5X TBE buffer by heating. 0.01% (v/v) ethidium bromide is included in the 
solution. 
 
- Phosphate-buffered saline (PBS): 8 g NaCl, 0.2 g of KCl, 1.44 g Na2HPO4 and 
0.24 g KH2PO4 were dissolved in 800 ml distilled H2O. pH was adjusted to 7.4 by drop 
wise addition of concentrated HCl and the buffer was completed to 1 L with distilled 
H2O. 
 
- 2X HEPES-buffered saline: 0.8 g NaCl, 0.027 g Na2HPO4.2H2O and 1.2 g 
HEPES were dissolved in 90 ml of distilled H2O. pH was adjusted to 7.05 with 0.5 M 
NaOH and the solution was completed to 100 ml with distilled water. The buffer was 
filter-sterilized. 
 
- Trypan blue dye (0.4% w/v): 40 µg of trypan blue was dissolved in 10 ml PBS.  
 
- 0.1% or 1% Triton X-100 Lysis Buffer: 60mM Na2HPO4, 40 mM NaH2PO4, 
10mM KCl, 1mM MgSO4 and  0.1% or 1% Triton X-100 at pH 7. 
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3.2  Methods 
3.2.1  Culture growth 
3.2.1.1  Culture of bacterial cells 
3.2.1.1.1  Liquid culture 
The E.coli cells were grown overnight (16-18 hours) at 37°C shaking at 270 rpm 
in Luria Broth. Selective antibiotics were added to the media depending on the 
application.  
3.2.1.1.2  Solid culture 
The E.coli cells were grown overnight in Luria Agar overnight (16-18 hours) at 
37°C. Cells were either spreaded or streaked on to solid agar plates. Antibiotics were 
added where necessary. 
3.2.1.2  Culture of Mammalian cells 
3.2.1.2.1  Culture of adherent cells 
293T cells were grown in 5% CO2 at 37°C in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 2 mM L-glutamine, 10% fetal bovine serum, 100 unit/ml 
Streptomycin and 100 unit/ml Penicillin. Cell cultures were washed with PBS, 
trypsinized and splitted in every 2-3 days by 1/10dilutions. 
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3.2.1.2.2  Culture of suspension cells 
EL4 cells were grown in 5% CO2 at 37°C in RPMI 1640 medium supplemented 
with 2 mM L-glutamine, 10% fetal bovine serum, 100 unit/ml Streptomycin and 100 
unit/ml Penicillin. Cell cultures were splitted in every 2-3 days by 1/10dilutions. 
3.2.1.3  Frozen stock preparation  
 E.coli cells were grown overnight at 37°C and stored in Luria Broth containing 
15% glycerol. Cells were frozen in liquid nitrogen and stored at -80°C.  
  
EL-4 and 293T cells at mid to late growth phase were resuspended in freezing 
medium (10% DMSO in fetal bovine serum) and stored at -80°C for 48 hours. Then, the 
cells were stored in liquid nitrogen tank. After thawing, cells were immediately washed 
with medium to get rid of DMSO. 
3.2.2  Construction of vectors 
3.2.2.1  Transformation of bacteria 
Competent cells were prepared with E.coli DH5α strain as described in Ausubel 
et al., 2002. ∆56fosCAT, pGL3 Basic, pGL3 Enhancer, pGL3 Control and pMaxGFP 
plasmids were transformed to competent E.coli cells according to Sambrook et al., 
2001. Transformed cells were spreaded on Luria Agar plates containing appropriate 
antibiotics. Luria Agar was supplemented with ampicillin as the selective marker for 
cells transformed with ∆56fosCAT and pGL3 plasmids. Kanamycin was used in the 
case of pMaxGFP. 
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3.2.2.2  Isolation of plasmid DNA 
 Plasmid isolations were done either by following the alkaline lysis protocol in 
Sambrook et al., 2001 or with the Qiaprep Spin Miniprep and Qiagen Midi kits. E.coli 
cells were picked up by toothpick and the cells were grown overnight at 37°C overnight 
prior to plasmid isolation. Chloramphenicol was added to medium when growing DH10 
cells carrying BAC clones. Other antibiotics were supplemented to the medium as 
mentioned in the previous section. BAC vector (RP23-365P6), ∆56fosCAT, pGL3 
Basic, pGL3 Enhancer, pGL3 Control and pMaxGFP plasmids were isolated. 
Concentration of each plasmid was determined by spectrophotometry at 260 nm. 
3.2.2.3  Construction of pGL3fos 
3.2.2.3.1  Restriction enzyme digestion 
Amount of restriction enzymes did not exceed 10% of the reaction mixture. 
Appropriate buffers were used for each enzyme according to the supplier information 
for all digestions. All digestion reactions were carried out at 37°C for 1-2 hours. 
 
Isolated pGL3 Basic plasmid was linearized by Hind III digestion. ∆56fosCAT 
plasmid was double digested with Xba I and Sal I to extract the fos promoter. Double 
digestion conditions were followed from the supplier web site (www.promega.com). 
 
Linearized pGL3 Basic vector was dephosphorylated at the 5’ protruding end by 
bovine intestinal alkaline phosphatase (CIAP). CIAP was added directly to the 
restriction enzyme reaction mixture after the completion of reaction. Unit of CIAP for a 
reaction was determined according to the supplier instructions and moles of DNA to be 
dephosphorylated. Dephosphorylation reactions were performed at 37°C for 30 min. 
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3.2.2.3.2  Agarose gel electrophoresis 
Agarose gels were prepared by polymerization of agarose in 0.5X  Tris-Borate- 
EDTA (TBE) buffer by heating 1-3 minutes in a microwave oven and cooling 20-30 
minutes at room temperature. 0.5X TBE buffer was also used as the electrophoresis 
buffer. 6X loading dye was mixed with the DNA samples at a 1:5 ratio. DNA samples 
were run on 1% agarose gels at 100-110 Volts for 40-60 minutes  
 
 Linearized pGL3 Basic and double digested ∆56fosCAT samples were applied 
to 1% agarose gel. Linearized pGL3 Basic and fos promoter fragment were extracted 
from agarose gel by Qiaquick Gel Extraction Kit according to the supplier’s 
instructions. 
3.2.2.3.3  Blunt ending of linearized pGL3 Basic vector 
5’ overhangs of pGL3 Basic vector and fos promoter were made blunt by DNA 
Polymerase I Large (Klenow) fragment according to supplier’s manual (Promega). 
Blunt ending reactions were done at 24°C for 30 min. Blunt ended DNA fragments were 
purified by Qiaquick PCR purification kit according to the instruction manual. 
3.2.2.3.4  Blunt end ligation 
Blunt ended fragments were ligated by T4 DNA ligase at 3:1 insert to vector 
molar ratio. Different from the supplier information (Promega), we added 50% PEG 
4000 to the 20 ml of ligation mixture. Ligation was carried out at 16°C for 18 hrs. 
Vector only ligations were also performed to evaluate the self circularization. 10µl of 
the ligation mixture was transformed into E.coli and plasmid isolations were performed 
as described in section 3.2.2.2.  
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3.2.2.4  Construction of pGL3fos Enhancer 
Constructed pGL3fos and pGL3 Enhancer plasmids were double digested with 
BamH I and Nco I restriction enzymes and linearized pGL3fos vector was 
dephosphorylated with CIAP as described in section 3.2.2.3.1. Digestion products were 
run on agarose gel and purified from gel as described in section 3.2.2.3.2. Linearized 
pGL3fos and extracted SV40 enhancer + luciferase cDNA fragment that have sticky 
ends were ligated by T4 DNA polymerase at 3:1 insert to vector molar ratio. Ligation 
mixtures were transformed into E.coli and plasmid isolation was performed from 
colonies as described in Section 3.2.2.2. 
3.2.2.5  Construction of pGL3fos-Kpl vectors 
3.2.2.5.1  Identification of conserved noncoding regions 
 Mouse, human and rat genomic sequences representing the IL-7R gene upstream 
region were downloaded from UCSC genome browser (http://www.genome.ucsc.edu). 
Exon files were generated by the Spidey program available at the NCBI web site 
(http://www.ncbi.nlm.nih.gov/IEB/Research/Ostell/Spidey/). The sequences were 
aligned by AVID and similarity plot was generated by VISTA program both are 
available at the VISTA server (http://www-gsd.lbl.gov/vista/). 50 bp window length and 
85% minimum similarity parameters were set to VISTA. (see details in section 4.1)  
3.2.2.5.2  Amplification of mouse conserved noncoding sequences 
Conserved noncoding sequences were amplified from RP23-365P6 BAC vector by 
PCR. Reaction volumes and final concentrations of PCR components were determined 
according to supplier’s recommendations (Promega). Primers were designed to amplify 
the mouse genomic regions that were identified as conserved noncoding sequences 
(CNS) using the Primer3 program (http://frodo.wi.mit.edu/primer3). A Sal I site was 
added to the 5’ end of each primer (Appendix E). 
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PCR thermal cycle conditions: 
 
2 min  at 95°C Initial denaturation 
0.5 min  at 95°C Denaturation 
1 min  at 56°C Annealing   30 cycles 
2 min  at 72°C Extension 
5 min  at 72°C Final extension 
Infinite  at 4°C Hold 
3.2.2.5.3  Insertion of PCR products into pGL3fos vector 
PCR products (Kpl7-Kpl13) and pGL3fos vector were digested with Sal I in order 
to get compatible sticky ends. PCR products were purified by Qiaquick PCR 
purification kit. Linearized pGL3fos vector was dephosphorylated by CIAP as in 
section 3.2.2.3.1 and extracted from 1% agarose gel. Then, PCR products were ligated 
into the linearized pGL3fos vector. Ligations with only pGL3fos were performed to 
evaluate the self circularization of the vector. Ligation products were transformed into 
E.coli. Confirmation of the inserts into the vector was done by either restriction 
digestion followed by plasmid isolation or colony PCR.  
3.2.3  Confirmation of vector constructs 
3.2.3.1  Colony PCR 
 Colony screening of pGL3fos-Kpl constructs were initially confirmed by colony 
PCR method aiming to amplify the fragment inserted. Colonies were picked up from 
Luria Agar-ampicillin plates and swirled in 8.5 µl sterile dH2O in 20 µl PCR tubes and 
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streaked on replica plates. Cells were lysed for 8 minutes at 95°C. Same conditions with 
the first amplification of CNS regions from the BAC clone were used. Colony PCR 
results were analyzed on 1% agarose gel. 
3.2.3.2  Confirmation by restriction enzyme digestions 
According to the reaction conditions recommended by the supplier (Promega), 
diagnostic restriction enzyme digests performed for constructed vectors. The results of 
these digestions were analyzed on 1% agarose gel. We performed Hind III-Nco I double 
digestions in order to cut the fos promoter back from the pGL3fos vector. We also 
digested the pGL3fos vector by Xba I with the expectation that two large fragments 
would appear on agarose gel. Because a site for this enzyme was in the vector backbone 
and another site was generated after blunt end ligation. 
 
We performed Pvu II-Sph I double digestions for the constructed pGL3fos 
Enhancer vector. Pvu II has a site in fos promoter and Sph I has a site in luciferase 
cDNA and two proximal sites in SV40 enhancer sequence. On agarose gel, we expected 
to see three relatively large fragments and a short band in the length of 72 bp. 
 
In addition, a second confirmation for the pGL3fos-Kpl vectors was performed. 
Colonies which were determined to be positive for carrying the insert were analyzed by 
diagnostic digestions. Plasmid DNAs were isolated from positive colonies and digested 
with enzymes which have at least one site in the insert sequence and along the pGL3fos 
vector backbone. Same vectors were also digested with Sal I in order to excise the 
cloned fragment. All these restriction sites are indicated in the vector maps in appendix-
F. The results of these diagnostic digestions were analyzed on 1% agarose gel. 
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3.2.4  Mammalian cell transfections 
3.2.4.1  Electroporation 
 pGL3fos Enhancer, pGL3 Control and pmaxGFP plasmids were used in 
transfection of EL-4 cells by electroporation. 1-2x107 EL-4 cells at late growth phase 
were washed once with serum free medium. The cells were then resuspended in 500µl 
serum free medium and incubated 15 minutes after addition of 20 µg plasmid DNA. The 
cells transferred to electroporation cuvettes. Different electroporation conditions in the 
ranges of 200 to 400 V, 800 to 1800 µF and 25 to 400Ω were applied to EL-4 cells. 
Pulsed cells were incubated for an additional 15 minutes and transferred into 60 mm 
culture dishes. Cells were either harvested for luciferase activity or visualized for GFP 
expression. 
3.2.4.2  Calcium phosphate mediated transfections 
 293T cells were transfected with pGL3fos Enhancer, pGL3 Control and 
pmaxGFP plasmids by calcium phosphate mediated transfection according to the 
conditions in Sambrook et al., 2001. 293 T cells at 70% confluency were trypsinized 
and seeded in 60 mm dishes 24 hours prior to transfection. And the medium was 
refreshed 60 minutes before the transfection. 100 µl 2.5 M CaCl2, 25 µl plasmid DNA 
(~25 µg) was completed to 1 ml with 0.1X TE buffer (pH 7.6) and mixed with 1 ml 2X 
HEPES-buffered saline. The solution was incubated for 1 minute at room temperature 
and 100 µl of the solution was added to 1ml of the culture medium. The cells were 
incubated for 48 hours prior to analysis. 
 
The effect of the amount of plasmid DNA on transfection efficiency was 
investigated. Five different amounts of plasmid DNA were transfected. Each 1 µg, 3 µg, 
6.5 µg and 10 µg of pGL3 Control plasmid DNAs were used for calcium phosphate 
mediated transfection of 293T cells according to the conditions stated above. In 
addition, the effect of number of cells for each transfection was also analyzed. 0.25x106, 
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0.5x106, 1x106, 3x106 and 5x106 293T cells were seeded 24 hours prior to transfection 
with 6.5 µg pGL3fos Enhancer plasmid. 
3.2.5  Luciferase reporter gene assays 
 Luciferase reporter assays were performed according to manufacturer’s 
instructions with some modifications (Promega). Suspension cells were pelleted at 1000 
rpm, washed with PBS and resuspended in 400 µl lysis buffer. Adherent cells were 
lysed directly in 60mm dishes. Either reporter lysis buffer (RLB) (Promega), 0.1% or 
1% Triton X-100 buffers were used for lysing the cells. Cell lysis was performed by 
incubating the lysate 10-15 minutes with pipetting up and down. A single freeze-thaw 
cycle was done in some of the assays. Lysed cells were centrifuged at 12000 rpm and 
the supernatant was assayed for luciferase activity. Luciferase assay reagent was 
equilibrated to room temperature for 30 minutes. To measure the luciferase activity, 50 
µl cell lysate was mixed with 100µl luciferase assay reagent in 96 well black plates and 
luminescence was measured immediately in the luminometer. 
3.2.6  Protein content determination by Bradford assays 
 Protein standards were prepared with Bovine Serum Albumin (BSA) by diluting 
10 mg/ml BSA stock. 0.1-1 mg/ml BSA standards were prepared. 5 µl of each standard 
was mixed with 250 µl Bradford reagent (Sigma Aldrich) in 96-well plates. A 
microplate spectrophotometer was used to measure the optical density at 595 nm. To 
determine the protein concentration of cell lysates, 1-5 µl cell lysate was used and 
measurements were done by the same way with standards. 
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4  RESULTS 
As mentioned in Section 1.5.2, we aimed to use a reporter gene assay system to 
detect the transcriptional activation properties of various conserved noncoding 
sequences in the IL-7 gene locus. First we identified these conserved sequences using 
the computer programs AVID-VISTA (www-gsd.lbl.gov/vista). Next we obtained seven 
putative enhancer sequences by PCR from a specific BAC clone and cloned them into a 
modified firefly luciferase reporter plasmid. We modified the reporter vector by 
inserting a weak promoter sequence into it. Then we also constructed a control reporter 
vector containing the weak promoter and a strong enhancer sequence to assess the 
transcriptional ability of the promoter. 
 
We investigated the achievability of luciferase assay system for a human kidney 
fibroblast cell line due to its high transfection efficiency and high expression capability. 
We transfected these cells with luciferase control vectors as well as with a green 
fluorescent protein (GFP) carrying plasmid for visual detection of transfections. Since 
we needed an IL-7R expressing cell line in order to examine the transcriptional activity 
of the cloned sequences, luciferase control and GFP vectors were also introduced into a 
CD4+ single positive T-lymphoma cell line. For both cell lines, we evaluated the 
transcription efficiency at various conditions and analyzed the luciferase activity of 
strong regulatory sequences. 
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4.1  Comparative Analysis of Genomic Sequences 
4.1.1  Determination of genomic regions 
The IL-7R gene is located on mouse chromosome-15, human chromosome-5 and 
rat chromosome-2. IL-7R gene and upstream neighbouring genes or gene predictions 
were displayed in NCBI Entrez Gene web site (www.ncbi.nlm.nih.gov/entrez).  
    
a) 
 
   b) 
 
   c) 
 
 
Figure 4.1: Genomic locations of IL-7R and upstream neighbouring genes or gene 
predictions. C230086A09 and Gm923 on mouse chromosome-15 (a), FLJ23577 on 
human chromosome-5 (b) and RGD:620450 (Kpl2) on rat chromosome-2 (c) are all 
homologous to Klp2 gene. 
 
According to NCBI Entrez Gene (Fig 4.1), IL-7R upstream genes or gene 
predictions all show homology to Kpl2 gene which is first cloned and annotated in rat 
(Ostrowski et. al. 1999). Thus, IL-7R gene locus shows conservation between mouse, 
human and rat by means of location, orientation and homology of upstream genes. 
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4.1.2  Retrieval of genomic sequences 
Mouse, human and rat IL-7R gene loci were displayed on UCSC Genome 
Browser (http://www.genome.ucsc.edu). For mouse and human, May-2004 genome 
assemblies were used. For the rat, the available genome assembly was June-2003.  
 
 
 
Figure 4.2: Mouse IL-7R gene and upstream region including Kpl2 homologous gene 
AK041992 and its variant mRNA AK048961. 
 
 
 
Figure 4.3: Human IL-7R gene and upstream region including Kpl2 homologous gene 
FLJ23577. 
 
 
 
Figure 4.4: Rat genomic region corresponding to mouse and human IL-7R genes and 
upstream region including Kpl2 gene. 
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According to Figure 4.4, Kpl2 gene is located in the upstream region of IL-7R on 
rat choromosome-2. FLJ23577 gene (Fig 4.3) is the homolog of Kpl2 in human 
chromosome-5. In mouse chromosome-15, AK048961 cDNA (Fig 4.2) and gm923 
prediction (Fig 4.1.a) are Kpl2 homologs. Gm923 is a gene model predicted 
computationally with no experimental data; which is located between Kpl2 homolog 
AK048961 and il7r gene. AK048961 and gm923 occupy together a region that 
corresponds to the location of Kpl2 in rat genome. 
 
Boundaries of genomic regions to be used in comparative analysis were 
determined. Genomic regions spanning from 5’end of IL-7R gene to 10Kb upstream of 
Kpl2 homolog genes were obtained from UCSC genome browser as in Table4.1. When 
taking sequences, direction of IL-7R gene was accepted as the positive direction. 
Therefore, reverse complement of the genomic sequences was taken if IL-7R gene is in 
opposite direction to the chromosome it is located. 
 
Organism Chromosome 
number 
Starting 
point 
Ending 
point 
Direction 
taken 
Mouse 15 9,402,535 9,658,035 Reverse 
Human 5 35,643,746 35,912,678 Forward 
Rat 2 59,032,272 59,271,440 Reverse 
 
Table 4.1: Boundaries and directions of genomic sequences taken from UCSC genome 
browser. 
4.1.3  Alignment of genomic sequences 
Genomic sequences were aligned by AVID (www-gsd.lbl.gov/vista) which is a 
pairwise global alignment program (Bray et al., 2003). Following the alignment, 
conserved genomic sequences were visualized by VISTA that is a software used for 
visualizing global DNA sequence alignments of arbitrary length (Mayor et al., 2000).  
 
Genomic region at mouse chromosome-15 that is spanning from 9,402,535 bp to 
9,658,035 bp was selected as the base sequence for global alignment. Since the 
chromosomal location of sequences was not an input of AVID-VISTA, genomic region 
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between 9,402,535 bp - 9,658,035 bp corresponded to 1 bp - 255500 bp in the output of 
the alignment. Therefore, in the rest of the study, locations of sequences were given 
relative to 1 bp-255500bp aligned mouse sequence. 
 
Usually, exons of coding or predicted genes show high level of similarity 
compared to noncoding sequences. VISTA accepts an exon file which determines the 
location of coding regions. Thus, the program does not consider exons as conserved 
noncoding regions (CNS). An exon file was prepared by the use of NCBI Spidey 
program. The previously selected mouse genomic region (1 bp - 255500 bp) was given 
to Spidey (www.ncbi.nlm.nih.gov/IEB/Research/Ostell/Spidey/) as an input. 
Additionally, sequences of mouse IL-7R and AK048961 mRNAs and gm923 predicted 
mRNA were entered to Spidey for determination of exon locations. Table 4.2 shows the 
exon places of these mRNAs on the selected mouse genomic region.  
 
Since an exon file was created, VISTA did not report the exons as CNS regions. 
However, vertebrate noncoding genomic sequences usually contain lots of repeat 
regions that should be eliminated. VISTA optionally detects repeat sequences such as 
LINEs and SINEs and does not utilize these repeats as CNS regions. 
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Kpl2 Exons (bp) Gm923 Exons (bp) IL-R Exons (bp) 
9909 - 10066 
18164-18214 
19895-19903 
20145-20159 
20381-20385 
20904-20909 
29505-29759 
34121-34261 
35718-35782 
41838-42024 
42959-43147 
46539-46726 
55286-55454 
72240-72459 
75256-75407 
77562-77619 
79096-79148 
80817-80920 
83687-83943 
91399-91510 
93009-93166 
97142-98822 
112306-112374 
112818-112945 
113026-113164 
125691-125828 
129739-129890 
134225-134405 
147963-148116 
149595-149861 
152667-152805 
154913-155142 
164906-165012 
165620-165802 
169511-169603 
172418-172557 
172660-172828 
178058-178297 
178446-178568 
184506-184880 
231536-231733 
236202-236340 
245077-245234 
248527-248684 
250290-250458 
251310-251403 
252787-252862 
253211-255410 
 
Table 4.2: Exon locations of mouse mRNAs relative to mouse genomic sequence 
selected for comparative analysis. 
 
Mouse genomic region at chromosome-15 and corresponding human genomic 
sequence were aligned by AVID and visualized by VISTA (Fig 4.5). Window length 
was set as 50 bp. Another parameter was the minimum percent similarity that was 
determined as 85%. Therefore, non-exon sequences longer than 50 bp and having at 
least 85% similarity between the two genomes were reported as CNSs. 
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Figure 4.5: VISTA plot of mouse-human genomic sequences alignment with a window length of 50 bp. Regions showing 85% or higher 
similarity are displayed in pink and considered CNS. 
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Figure 4.5 (continued): VISTA plot of mouse-human genomic sequences alignment with a window length of 50 bp. Regions showing 85% or 
higher similarity are displayed in pink and considered CNS. 
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In addition to the similarity plot, exact locations of conserved regions which have 
higher similarity than 85% were reported. Table 4.3 shows the borders of conserved 
regions spanning 40 kb upstream from the first exon of IL-7R gene. Additionally, the 
last noncoding sequence was found in the second intron of IL-7R. Noncoding sequences 
were named as CNS I-X. Some of the conserved sequences correspond to IL-7R gene 
exons. Thus, these exon regions were not considered for further study. 
 
 Interval Length 
(bp) 
Percent 
similarity 
Status 
CNS I 191846- 191900 55 89.1% noncoding 
CNS II 194658- 194858 201 86.6% noncoding 
CNS III 199372- 199431 60 86.7% noncoding 
CNS IV 199440- 199488 49 87.8% noncoding 
CNS V 199713- 199774 62 83.9% noncoding 
CNS VI 225927- 225995 70 82.9% noncoding 
CNS VII 227818- 227877 60 86.7% noncoding 
CNS VIII 227882- 228047 167 91.6% noncoding 
CNS IX 231436- 231505 70 91.4% noncoding 
CNS X 237230- 237279 50 86.0% noncoding 
Exon 3 245148- 245217 70 87.1% coding 
Exon 5 250395- 250444 50 86.0% coding 
Exon 7 252787- 252857 71 90.1% coding 
Exon 8 253213- 253276 64 85.9% coding 
Exon 8 253664- 253715 52 88.5% coding 
 
Table 4.3: Intervals of conserved sequences relative to mouse genomic region of 
interest. 
 
Mouse-Rat and rat-human alignments were done for the same genomic region 
(data not shown). It is verified that, all the noncoding conserved sequences form CNS I 
to CNS X show also 85% or higher conservation in both mouse-rat and rat-human 
alignments. 
4.1.4  Determination of BAC clone 
For laboratory analysis of the identified conserved noncoding sequences, the 
specific mouse bacterial artificial chromosome (BAC) clone was required. Therefore, 
BAC clone database on UCSC genome browser was searched. RP23-365P6 BAC clone 
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was found to fully cover all the identified CNS sequences (Figure 4.6). For PCR 
amplification of CNS regions, RP23-365P6 BAC clone was used as template. 
 
 
 
Figure 4.6: Mouse RP23-365P6 BAC clone (indicated with arrow) covers IL-7R gene 
and its 40 Kb upstream region. 
4.2  Cloning of Conserved Noncoding Sequences 
4.2.1  PCR amplification of CNS regions 
Primers for amplification of CNS sequences from BAC clone were determined 
using the Primer3 program. Some primers were designed to amplify more than one 
CNS. Primers were selected to amplify additional ~200-300 bp sequences at both 5’ and 
3’ ends of CNS regions. Sal I site was included into 5’ end of primer sequences for 
ligation of PCR products into Sal I site of PGL3fos plasmid. Table 4.4 shows the 
boundaries of amplified fragments relative to aligned mouse genomic sequence. Since 
the identified conserved noncoding sequences are at the upstream region of IL-7R gene 
and Kpl2 gene is also found upstream of IL-7R, amplified fragments were named as 
Kpl1, Kpl2, ….., Kpl7. 
 
 45 
Primers PCR fragment Interval Length Covered CNSs 
Kpl7F & Kpl7R Kpl7 191602-200032 430 CNS I 
Kpl8F & Kpl8R Kpl8 194402-194969 567 CNS II 
Kpl9F & Kpl9R Kpl9 199149-199883 834 CNS III, IV, V 
Kpl10F & Kpl10R Kpl10 225061-226299 1238 CNS VI 
Kpl11F & Kpl11R Kpl11 227544-228299 755 CNS VII, VIII 
Kpl12F & Kpl12R Kpl12 231102-231494 492 CNS IX 
Kpl13F & Kpl13R Kpl13 237036-237577 541 CNS X 
 
Table 4.4: Boundaries of amplified fragments relative to aligned mouse genomic region. 
First column indicates the primers used for PCR and the last column shows the 
amplified conserved noncoding sequences. 
 
 
 
Figure 4.7: Analysis of PCR products containing CNS regions. 
 
Genomic sequences containing CNS regions were amplified by PCR. RP23-
365P6 BAC clone was used as template DNA. Figure 4.7 shows the amplified 
fragments on 1% agarose gel. It should be noted that the observed fragment lengths 
relative to the molecular weight marker, correlate with the expected fragment sizes 
indicated in Table.4.4. 
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In order to analyze the possible enhancer activity of the amplified CNS regions 
experimentally, a luciferase reporter vector with a weak promoter was required. 
Therefore, promoter of fos gene was cut out from the available source vector 
∆56fosCAT. Following section describes the blunt end ligation of fos promoter into 
pGL3 Basic luciferase reporter vector. 
4.2.2  Construction of pGL3fos vector 
∆56fosCAT was double digested with Xba I and Sal I. Double digestion yielded a 
fragment which corresponds to fos promoter with al length of 165 bp. 
 
 
 
Figure 4.8: Xba I-Sal I double digestion of ∆56fosCAT plasmid. 
 
The 165 bp fragment was extracted form agarose gel. The resultant 5’ protruding 
Xba I and Sal I ends of the fos promoter were made blunt by Klenow enzyme. 
 
200 bp  
 47 
pGL3 Basic vector was linearized by Hind III digestion and extracted from 
agarose gel. Similar to fos promoter, Klenow enzyme was used for blunt ending the 5’ 
protruding ends of linearized pGL3 Basic vector. 
 
Blunt-end ligation of fos promoter and pGL3 Basic was performed. When a Hind 
III blunt end is ligated to Sal I blunt end, a Hind III site is regenerated. However, when 
a Hind III blunt end is ligated to Xba I blunt end, an Xba I site is generated. Therefore, 
if the fos promoter was ligated in positive direction, the resultant vector construct must 
carry a Hind III site at the 5’ end of fos promoter and an Xba I site at the 3’ end. 
 
 
 
  
 
Figure 4.9: Blunt end ligation of fos promoter and pGL3 Basic vector. Hind III and Xba 
I sites are created on the construct vector are underlined. 
 
Ligation mixture was transformed into E.coli DH5α and spreaded on Luria Agar-
ampicillin plates. Resultant colonies were grown in Luria Broth-ampicillin medium and 
plasmid isolation was performed.  
 
For screening of constructs, plasmids isolated from each colony were double 
digested with Hind III and Nco I restriction enzymes. This digestion should give a 211 
bp fragment if the promoter was ligated in the positive direction. If the plasmid was a 
product of self ligation or the insert was reverse oriented, only a 33 bp fragment was 
formed by the double digestion and it could not be observed in 1% agarose gel. 
Colonies that gave 211 base pair fragment were accepted as positive. 
 
AAGCT : TCGAC TCTAG : AGCTT 
fos promoter 
pGL3 Basic pGL3 Basic 
HindIII 
blunt  
Sal I 
blunt  
HindIII 
blunt  
XbaI 
blunt  
HindIII XbaI 
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Figure 4.10: Analysis of Hind III-Nco I double digest of isolated plasmids. The 211 bp 
fragment contains fos promoter that is cut out from pGL3fos vector. 
 
pISI
4996 bp
luc+
Amp(R)
sv 40 Late PolyA Signal
Synthetic poly(A) signal 56 Promoter
f1 ori
COLE1 ORI SalI (2189)
HindIII (54)
NcoI (265)
XbaI (228)
XbaI (1921)
 
 
Figure 4.11: Map of constructed pGL3fos vector. Restriction sites: Xba I, Hind III and 
Nco I are used for diagnostic digests. 
 
Additionally, since an Xba I site was generated at the 3’ end of fos promoter upon 
blunt-end ligation, isolated plasmids were also digested with Xba I for further 
confirming the insertion of fos promoter into pGL3 Basic. This digestion should give 
pGL3fos 
 
4496 bp 
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3303 and 1693 bp fragments if the fos promoter was ligated in positive direction. On the 
other hand, if promoter was ligated in reverse direction, 3138 and 1858 bp fragments 
should be observed. Self ligation should give only one band in the length of pGL3 
Basic.  
 
 
 
Figure 4.12: Analysis of Xba I digests of isolated plasmids.  
 
According to figures 4.10, 4.11 and 4.12, presence of insert in positive direction 
was confirmed for plasmids isolated from colonies 2, 4, 5 and 8. Colony 3 seemed to 
have the insert in negative direction whereas colony 1 did not have the insert. In 
addition, colony 6 might have the insert however; its plasmid yield was low. 
4.2.3  Insertion of PCR fragments into pGL3fos vector 
Amplified PCR fragments and pGL3fos vector were digested with Sal I in order 
to create compatible sticky ends. PCR fragments containing CNS regions were ligated 
with the constructed pGL3fos. Ligation mixtures were transformed into E.coli DH5α 
cells and spreaded on Luria Agar- ampicillin plates. Colonies were screened in order to 
verify the insertion of the PCR fragments. For this purpose, plasmid DNAs were 
isolated and digested with Sal I. Following the analysis on agarose gel, colonies that 
gave fragments in the length of inserted PCR products were confirmed. 
 
However, plasmid isolation and restriction digestion is a time consuming 
procedure for screening several ligations, initial confirmation for most ligations were 
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done by colony PCR method. Colony PCR products were visualized on agarose gel and 
colonies that gave fragments at the size of inserts were accepted as positive. 
 
After plasmid isolation of positively selected colonies, another confirmation step 
was performed. Apart from the Sal I sites located at both ends of ligated inserts, 
restriction enzyme sites inside the cloned PCR fragments were determined. These 
selected restriction sites are also represented in PGL3 Basic vector by at least one site. 
Each isolated plasmid was digested with those restriction enzymes as indicated in Table 
4.5. It should be noted that Kpl12 fragment does not have an available restriction site. 
Expected fragments in case of inserts were ligated in forward direction are given in 
Table 4.5. However, since directional cloning was not aimed, some of the inserts were 
ligated in reverse direction.  
 
Vector Restriction enzyme sites Expected Fragment Length 
(bp) 
pGL3fos-Kpl7 Pvu II 3231 
2201 
pGL3fos-Kpl8 Xmn I 3573 
1912 
84 
pGL3fos-Kpl9 Xba I 3426 
1693 
717 
pGL3fos-Kpl10 Sma I 3395 
2845 
pGL3fos-Kpl11 Nco I 3328 
2429 
pGL3fos-Kpl12 
 
- - 
pGL3fos-Kpl13 Hind III 3277 
2266 
 
Table 4.5: Restriction enzyme sites inside the cloned sequences. Last column shows the 
expected fragment lengths when the vector constructs in the first column were digested 
with indicated restriction enzymes. Fragment lengths correspond digestion products in 
the case of ligation in forward direction. 
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A)                 B) 
 
 
Figure 4.13: Colony screening and diagnostic digestions for 
Kpl7 insert A) Sal I digestion of plasmids isolated from 
colonies for screening Kpl7 insertion into pGL3fos. B) 
Analysis of Sal I and Pvu II digestions of constructed 
pGL3fos-Kpl7 vector. UD represents undigested plasmid. 
 
Transformed colonies were screened for Kpl7 insertion into pGL3fos vector by 
Sal I digestion of isolated plasmids. Colony number 12 gave a fragment in the length of 
Kpl7 (Figure 4.13.A). After midiprep plasmid isolation, Pvu II digest was performed. 
The length of resultant fragments indicates that Kpl7 was ligated in reverse direction. 
As can be seen from pGL3fos-Kpl7 vector map (appendix F), when Kpl7 is ligated in 
reverse direction, Pvu II digest gives two fragments. 3017 bp and 2415 bp fragments 
correlate with the bands observed on the third lane in Figure 4.13.B. 
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    A)                      B) 
 
 
 
 
 
 
 
Figure 4.14: Analysis of colony PCR results for screening 
Kpl8 insertion into pGL3fos (A). Sal I and Xmn I 
digestions of constructed pGL3fos-Kpl8 vector (B). 
 
 
 
 
In order to screen Kpl8 insertion into pGL3fos vector, colony PCR method is 
performed for colonies transformed with ligation mixture. Primers designed for 
amplification from BAC clone were used. Kpl8 insert was amplified from two colonies 
as can be seen in Figure 4.14.A lanes two and four. Additionally, Sal I digest for 
isolated plasmid gave a band in the length of Kpl8. Moreover, Xmn I digest gave the 
expected fragments for pGL3fos-Kpl8 as indicated in Table 4.5 although a 84 bp band 
could not be observed in 1% agarose gel. 
 
    
       A)              B) 
 
Figure 4.15: Colony PCR results for screening Kpl9 (A) and Kpl10 (B) insertions into 
pGL3fos. Mass Ruler Low Range and Gene Ruler 1kb molecular weight markers are 
used respectively. 
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Figure4.16: Restriction enzyme digestion analysis of pGL3fos-Kpl9 and pGL3fos-
Kpl10 vectors.  
 
After selection of positive colonies by colony PCR screening (Figure 4.15), 
pGL3fos-Kpl9 and pGL3fos-Kpl10 vectors are digested with the indicated enzymes in 
Figure 4.16. Sal I digests gave bands equal to the lengths of Kpl9 and Kpl10 inserts. 
Xba I digest of Kpl9 and Sma I digest of Kpl10 gave fragment lengths that correlate 
with Table 4.5. Therefore, it can be concluded that Kpl9 and Kpl10 were successfully 
cloned into pGL3fos vector. 
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    A)    B) 
       
 
Figure 4.17: Analysis of colony PCR results for Kpl11 (A) and Kpl13 (B) insertions 
into pGL3fos vector. 
 
 
 
Figure 4.18: Agarose gel electrophoresis for restriction enzyme digestion products of 
constructed pGL3fos-Kpl11 and pGL3fos-Kpl13 plasmids. 
 
Kpl11 PCR product was ligated with pGL3fos vector. Positive colony was 
selected by colony PCR (Figure 4.17.A). Insertion of Kpl11 was confirmed by Sal I and 
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Nco I digestions (Figure 4.18). Sal I digest gave a band in the length of the Kpl11 insert. 
In addition, Nco I digested the vector into two fragments whose sizes were consistent 
with the expected results indicated in Table 4.5. Kpl13 fragment was also inserted into 
pGL3fos plasmid. Hind III digest of pGL3fos-Kpl13 gave two fragments whose lengths 
were consistent with the expected fragment sizes (2992 bp and 2551 bp) in the case of 
reverse ligation. Kpl13 PCR fragment was inserted in reverse direction as in the vector 
map (Appendix F). 
 
     
A            B 
Figure 4.19: Colony PCR (A) and Sal I digestion (B) of pGL3fos-Kpl12 vector. 
 
pGL3fos-Kpl12 positive colonies were selected by colony PCR (Figure 4.19 A). 
Since no available restriction enzyme could be identified in Kpl12 sequence, only Sal I 
digest was performed for confirmation which cut the Kpl12 fragment back (Figure 
4.19.B). 
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4.3  Transient Transfection of EL-4 and 293TCell Lines with pmaxGFP 
Due to the simple analysis of GFP by fluorescence microscopy, pmaxGFP vector 
was selected for monitoring the transfection efficiency. pmaxGFP encodes the green 
fluorescent protein (GFP) from Copepod potellina species. Although the main goal of 
this study was evaluating luciferase reporter activity in EL-4 T-lymphoma cells, these 
cells were also transfected with pmaxGFP to examine the success of transfections. In 
addition to EL-4 cells, 293T cell line, which is a human embryonic kidney fibroblast 
cell line, was used. Due to efficient transfection and high expression properties of 293T 
cells, these cells were transfected with pmaxGFP in order to compare the GFP 
expression profiles with transfected EL-4 cells. 
 
 
 
Figure 4.20: pmaxGFP transfected 293T cells visualized by fluorescence microscopy at 
200X magnification. 
 
pmaxGFP was introduced into 293T cells by calcium phosphate mediated 
transfection. 0.5x106 cells were seeded 24 hours prior to transfection and 6.5 µg DNA 
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was used. 48 hours after transfection, 293T cells were monitored under fluorescence 
microscope in order to evaluate their transfection efficiency and GFP expression.  
 
EL-4 cells were transfected with pmaxGFP by electroporation. Several 
electroporation conditions were tested to improve the efficiency. After examining 
numerous experimental conditions, best transfection efficiency was obtained at 300V, 
1200µF and 200Ω. Transfected cells were visualized by fluorescence microscopy. 
 
 
 
Figure 4.21: pmaxGFP transfected EL-4 cells visualized by fluorescence microscopy at 
200X magnification. 
 
Transfections results of the two cell lines (Figures 4.20 and 4.21) were different in 
terms of percentage of light emitting cells, meaning that 293T cells were more 
efficiently transfected than EL-4 cells. Transfection efficiency of 293T cells was 
evaluated as 35-40%, whereas EL-4 cells were transfected at 15-20%. Moreover, 
transfected 293T cells emitted green light at a greater intensity compared to EL-4 cells. 
This suggested that 293T cells expressed greater levels of GFP protein than the EL-4 
cells did. 
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4.4  Luciferase Reporter Assays 
4.4.1  Construction of pGL3fos-Enhancer Plasmid 
Aim of the present study was examining the putative transcriptional activities of 
various conserved noncoding sequences (CNS) located in IL-7R gene locus. For this 
purpose, one intronic and six upstream CNSs are cloned into pGL3fos plasmid. 
pGL3fos was constructed by inserting the weak fos gene promoter into the downstream 
of luciferase gene in the pGL3 Basic vector.  
 
To evaluate the transcriptional efficiency of fos promoter, we needed a strong 
enhancer sequence. I selected SV40 enhancer in order to insert into pGL3fos vector and 
to use a positive control. pGL3 Enhancer vector contains a SV40 enhancer at the 
downstream of luciferase cDNA. However, suitable restriction enzyme sites could not 
be found for cutting and ligating only the SV40 sequence. Therefore, SV40 enhancer 
was excised from pGL3 Enhancer vector together with the luciferase cDNA. The 
fragment containing both SV40 enhancer and luciferase cDNA was replaced with the 
luciferase gene of pGL3fos plasmid in order to construct the pGL3fos Enhancer vector. 
 
 
 
Figure 4.22: BamH I-Nco I double digestion for pGL3 Enhancer and pGL3fos vectors. 
Mass Ruler High Range was used as molecular weight marker. 
 
Fragment containing SV40 enhancer and luciferase cDNA was extracted from pGL3 
Enhancer vector by BamH I-Nco I double digestion (2164 bp fragment in Figure 4.22 
lane 2). At the same time, luciferase cDNA was removed from pGL3fos plasmid by the 
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same double digestion. Then, the fragment containing SV40 enhancer and luciferase 
cDNA was ligated with the linearized pGL3fos which lacks luciferase cDNA (3078 bp 
fragment in Figure 4.22 last lane). Construction of pGL3fos Enhancer vector was 
confirmed by Pvu II-Sph I double digestion. Pvu II has a site in fos promoter, while Sph 
I has two sites in SV40 enhancer and a single site in luciferase cDNA. Pvu II and Sph I 
do not have any other restriction sites in the backbone plasmid pGL3 Basic. 
 
 
 
Figure 4.23: Analysis of Pvu II-Sph I double digestion of pGL3fos Enhancer vector. 
 
Construction of pGL3fos Enhancer was confirmed. Expected fragment lengths 
from Pvu II-Sal I double digestion was 2982, 1357, 811 and 72 base pairs. Except the 
72 bp fragment which could not be seen on 1% agarose gel, all bands in the above 
figure were consistent with expected sizes.  
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4.4.2  Determining the linear range of luminescence detection  
Luciferase reporter activity can be measured by a number of commercially 
available luminometers. However, linear range of detection may vary among different 
instruments. For his purpose, purified recombinant luciferase enzyme was used to 
produce a calibration curve to evaluate the linear range of SpecraMax GeminiXS 
microplate spectrofluorometer (Molecular Devices Inc.). At various enzyme 
concentrations, luminescence values were measured.50 ml of each standard was mixed 
with luciferase assay reagent. 
 
 
 
Figure 4.24: Standard curve for determination of linear range of luminescence detection. 
Note that values were plotted logarithmically. 
. 
As can be seen from the calibration curve in Figure 4.24, measured luminescence 
levels were in a good linear relationship with the luciferase enzyme quantities that were 
higher than 75 pg/well. On the other hand, the low end of the curve was not in the linear 
range of detection. This means that the luciferase amounts lower than 75 pg/well could 
not be reliably measured. For this purpose, we decided to find out the lower limit of 
detection of the instrument. Lower limit of detection is defined as the three positive 
standard deviations added to the average of statistically significant number of blank 
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measurements (McGown et al., 2000). Blank measurements were done by mixing only 
the lysis buffer with the luciferase assay reagent. We found the blank value as 51±16 
RLU which indicated that the lower limit of detection was 99 RLU at 99% confidence 
level. This result showed consistency with the standard curve data because 99 RLU 
approximately corresponds to 75 pg/well luciferase that is the lowest point in the linear 
range of detection in the standard curve. 
4.4.3  Transfection of 293T cell line for luciferase assay 
Since 293T cells showed greater transfection efficiency compared to EL-4 cells 
(Section 4.3), 293T cells were also assayed for luciferase activity measurements. 293T 
cells were transfected with pGL3 Control vector in order to confirm that luciferase 
reporter system works well. pGL3 Control vector contains a SV40 promoter and a SV40 
Enhancer. These strong transcriptional elements provide the expression of flanking 
genes in most mammalian cells. So that, pGL3 Control vector was introduced into 293T 
cells as a positive control. In addition, the constructed pGL3fos Enhancer vector was 
transfected into 293T cells to examine the transcriptional activity of inserted fos 
promoter. 
 
Luciferase reporter gene assay was accomplished for 293T cells by calcium 
phosphate mediated transfection. 24 hours prior to transfection 5x106 cells were seeded 
in a 60 mm plate. 50 µL of each cell lysate was mixed with 100 µL luciferase assay 
reagent and the reaction was observed in microplate luminometer. Luciferase reporter 
activity of cells transfected with various DNA concentrations were examined (Figure 
4.25). 293T cells were transfected with different amounts of pGL3 Control vector. 
However, a significant deviation could not be detected between these conditions. 
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Figure 4.25: Luciferase activity of 293T cells transfected with different amounts of 
pGL3 Control vector. 
 
In addition to examining the effects of different DNA concentrations, number of 
cells was titrated from 0.25x106 to 5x106 in 60 mm tissue culture plates. As seen in 
Figure 4.26 highest luciferase activity (~100000 RLU) was observed in the sample with 
the lowest seeding density. On the other hand, transfections with higher seeding 
densities yielded approximately ten fold decrease in luciferase activity.  
 
 
Figure 4.26: Luciferase activity of 293T cells transfected with pGL3 Control vector at 
different cell densities. X-axis shows the number of cells seeded 24 hours prior to 
transfection. 
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As well, the constructed pGL3fos Enhancer vector was transfected into 293T cells 
to examine the transcriptional activity of inserted fos promoter. 0.25x106 293T cells 
were transfected with 6.5 µg DNA. Luciferase activity was measured as 4500 RLU 
which indicated that fos promoter was functional for transcriptional activity. 
4.4.4  Transfection of EL-4 cell line for luciferase assay 
Since luciferase reporter gene assay was accomplished for 293T cell line 
successfully, we investigated the EL-4 T-lymphoma cell line for luciferase activity in 
response to positive control vector. pGL3 Control and pGL3fos Enhancer vector were 
transfected into EL-4 cells. Several transfection and cell lysis conditions were tested. 
Transfections were performed in the electroporation conditions that gave the best 
transfection efficiencies when the cells were transfected with pmaxGFP. For the lysis of 
the cells, reporter lysis buffer (RLB) from Promega, 0.1% TritonX-100 or 1% TritonX-
100 buffers were used in independent experiments. However, a significant luciferase 
activity could not be measured. We could not observe a luminescence measurement 
higher than 99 RLU which is found to be the lower limit of detection of the instrument 
(Section 4.4.2.2).  
 
We determined protein concentrations in the cell lysates by Bradford assay, and 
confirmed that cells were lysed successfully. We first prepared a standard curve with 
different BSA (Bovine serum albumin) concentrations between 0.1-1.4 mg/ml. Then, 
we measured the total protein concentration in cell lysates. Cell lysis for different 
transfection experiments and with different lysis buffers gave protein concentrations in 
the range of 0.3-1.0 mg/ml. This indicated that an inefficient lysis was not the reason for 
the absence of luminescence. 
 
Transfections of EL-4 cells with the positive control vectors did not yield a 
significant luciferase activity. For this reason, constructed pGL3fos-Kpl plasmids 
containing mouse CNS regions were not assayed for transcriptional activity.  
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5  DISCUSSION 
As lymphocytes differentiate from bone marrow precursors to functional mature 
cells, they express IL-7R at distinct stages, indicating that IL7 survival signals are 
tightly regulated (Munitic et al., 2004). Although a few transcription factors have been 
reported to bind to the promoter region of IL-7R gene (Xue et al., 2004; DeKoter et al., 
2002), a key factor for the temporal and cell specific regulation has not been identified. 
In this study we followed a strategy for analyzing the transcriptional regulation of IL-7R 
gene. We used a bioinformatics approach to identify possible regulatory elements 
conserved at the upstream region of the IL-7R gene. Then we cloned these conserved 
noncoding sequences into a reporter vector. After that, we examined the practicability of 
luciferase reporter gene system in two different cell lines.  
5.1  Comparative Analysis 
Initiation of transcription requires binding of specific factors to promoter 
sequences as well as to a variety of regulatory elements frequently located far from the 
transcription start site (Rutherford, 2000). These cis-regulatory elements may be 
conserved between different species and may be located at tens to hundreds of kilobases 
away from the gene (Mortlock et al., 2003). Therefore, we aimed to study the 
transcriptional activation capability of a number of conserved noncoding sequences 
(CNS) located several kilobases away at the upstream of IL-7R gene. 
 
 First, we determined the homology of IL-7R upstream sequences among different 
organisms. We found that a neighbouring gene called Kpl2 is located at the upstream of 
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IL-7R gene in rat genome. Furthermore, the same gene was found to reside at a similar 
position in mouse, human and in a few mammalian species. Although these sequences 
could exist with different aliases due to the complexity in nomenclature, all of them 
have been shown as Kpl2 similar sequences. Therefore, we confirmed the homology of 
genomic loci to compare.  
 
For performing a comparative analysis, we then determined the organisms whose 
genomic sequences were to be compared. We aligned the homologous loci between 
several organisms and monitored the conservation among their genomic sequences 
(Data not shown). We ended up with a very low conservation between distinctly related 
organisms (chicken and human) and could observe only a few highly conserved 
noncoding regions. Conversely, between the closely related species such as human and 
chimpanzee, conservation was much greater that was unlikely to be considered as the 
preservation of functional sequences. These results indicated that moderately related 
organisms were a better choice for comparative analysis in order to reliably explore 
noncoding conserved sequences.  
 
We decided to perform a global alignment between mouse and human genomic 
loci containing more than 200 kilobases upstream and intronic sequences of IL-7R gene. 
Due to the high percentage of unfunctional repeat sequences in vertebrate genomes, we 
eliminated those sequences in order to prevent false positive consideration. We set the 
minimum conservation level and window length parameters that define which 
sequences will be monitored as CNS regions by VISTA. More than twenty noncoding 
sequences were determined to be conserved among the 255.5 kilobase region. 
Considering the required labor and time, for primary investigation, we preferred to 
analyze six of these sequences that were located in a 40 kilobase region at the upstream 
of IL-7R gene. In addition, one CNS inside the second intron of IL-7R gene was also 
selected for analysis. Since we planned to further analyze conserved mouse genomic 
sequences, we determined the positions of CNS regions relative to the aligned mouse 
genomic region for simplicity. 
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5.2  Construction of Vectors 
As we identified CNS regions in mouse genomic sequence, we amplified these 
sequences from a BAC clone which corresponds to the sequences of our interest. When 
designing primers for amplification, a Sal I restriction enzyme site was added to the 5’ 
end of each primer in order to insert the PCR fragments into the Sal I site of the reporter 
plasmid. In addition to the Sal I site, the primers were extended by five bases at the 5’ 
end to allow the Sal I enzyme to bind to the PCR products efficiently. After ligation of 
PCR products into the luciferase reporter vector, we applied Sal I digestions in order to 
confirm the insertion of the amplified fragments in the proper lengths. However, the 
ligation efficiency was found to be low and required screening a lot of colonies. We 
decided to increase the insert to vector ratio to increase the efficiency. In addition, we 
used colony PCR method for the conformation of inserts. This strategy was not only 
time saving compared to plasmid isolations followed by restriction enzyme digestions, 
but also eliminated the requirement of using lots of enzyme. After selecting the positive 
colonies, we performed further confirmation digestions with Sal I and other restriction 
enzymes. Each of these restriction enzymes was confirmed to have at least one 
recognition site inside the cloned PCR fragment and through the vector backbone. 
 
The reporter vector which we cloned the amplified CNS sequences into, was 
prepared by modifying the pGL3 Basic luciferase vector. We inserted a weak promoter 
into the 5’ end of luciferase cDNA in the reporter vector. The reason why we selected a 
weak promoter was that, a weak promoter would not mask the transcriptional activity of 
the noncoding conserved sequences to be analyzed. We constructed a positive control 
plasmid in order to use in luciferase assays. Since the conserved sequences were cloned 
into the downstream of luciferase cDNA that is controlled by a weak promoter, we 
needed a strong enhancer to check the transcriptional activity of this promoter. For this 
reason, we inserted the SV40 strong enhancer sequence into the reporter vector. 
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5.3  Transfections and Luciferase Assays 
We used 293T cell line in the transfection experiments in order to allow a 
comparison with the EL-4 cell line. EL-4 cell line is a CD4+ single positive T-
lymphoma suspension cell line that is known to be IL-7R positive. We evaluated the 
transfection efficiencies and luciferase reporter activities. 293T cells are adherent 
human kidney fibroblast cells that have efficient protein expression capacity. Therefore, 
we transfected both 293T and EL-4 cells with pmaxGFP plasmid by calcium phosphate 
mediated transfection and electroporation respectively. Monitoring by fluorescence 
microscopy indicated that EL-4 cells were transfected at a much lower efficiency than 
293T cells. Several electroporation conditions were tried and a maximum of 15-20% 
efficiency has been achieved. When harsher electroporation conditions were applied, 
viability of the cells severely reduced. 
 
Then, we transfected 293T cells with the constructed pGL3fos Enhancer plasmid 
in order to detect luciferase activity. Cell lysates were positive for reporter gene activity 
suggesting that the fos promoter was efficient for transcriptional activation mediated by 
the strong SV40 enhancer sequence. In addition, we tested the luciferase activity at 
different luciferase conditions. Titrated DNA concentrations and cell numbers were 
analyzed. DNA concentration was found not to be critical for produced luciferase 
activity. On the other hand, number of cells that were seeded 24 hours prior to 
transfection dramatically affected the luciferase activity. Interestingly, transfection of 
smaller number of cells resulted in several folds of increase in activity. This indicated 
that transfection of the reporter plasmid and expression of the reporter gene was more 
efficient when lower number of cells were used. In contrast, transfection of pGL3fos 
Enhancer vector into reduced number of EL-4 cells did not gave rise to an increased 
luciferase activity. This may be because of the distinct properties of calcium phosphate 
mediated transfection and electroporation methods to introduce DNA into cells. It 
should also be noted that dissimilar culture growth and physiological characteristics of 
the two cell lines may cause differences in utilization of the reporter vector. 
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 We performed several electroporation experiments to introduce pGL3 Control 
and pGL3fos Enhancer vectors in order to evaluate the practicability of luciferase 
reporter system in EL-4 mouse T-lymphoma cells. However, we could not find a 
reliable luciferase activity in these cells. We checked the efficiency of lysis by protein 
determination assay and found that lysis was efficient. All of the luminescence 
measurements were out of the linear detection range of the luminometer (Section 4.4.2). 
In addition, all the measurements were under the range of lower limit of detection of the 
instrument (~75 pg luciferase per well) which is determined by summing the average of 
significant number of blank measurements with the three standard deviations (average 
of blanks ± 3 SD). Therefore we can conclude that the luminometer that we used was 
not sensitive enough for measuring luciferase levels lower than 75 pg/well. However, 
luminometers that are sensitive up to a few femtograms of luciferase are available. 
Thus, we need to reexamine the reporter vector constructs by the luciferase assay 
system with a more sensitive luminometer or by different reporter gene methods. 
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6  CONCLUSIONS AND FUTURE WORK 
In this study we followed a strategy that combined bioinformatic and molecular 
cell biology approaches to investigate the upstream transcriptional regulation of IL-7R 
gene. IL-7 signalling is essential for the development and survival of B- and T-
lymphocytes. Lymphocytes at distinct stages differentially express IL-7R on their 
surfaces, which determines their response to IL-7 signalling. Although there are studies 
on the transcriptional regulation of IL-7R expression, these findings were insufficient to 
explain the cell specific and temporal expression of IL-7R. For this purpose, we 
identified conserved noncoding sequences in the IL-7R gene locus that may have 
transcriptional activities and cloned these sequences into a luciferase reporter vector in 
order to evaluate their transcriptional capabilities. 
 
We tested the performability of luciferase assay with two cell lines by transfecting 
them with reporter vectors containing strong activator sequences. Although, the human 
kidney fibroblast cell line was efficient for the luciferase reporter activity, the mouse 
CD4+ single positive T-lymphoma cell line did not give a sufficient luciferase activity. 
To increase the efficiency of the reporter assay, a luminometer with a higher sensitivity 
can be used. In addition, a reliable normalization vector can be co-transfected into the 
cells in order to minimize the deviation between samples caused by external and cellular 
factors (Section 1.5.2.2). Vectors carrying reporter genes such as β-galactosidase or 
renilla luciferase under the control of weak or moderately strong promoters can be used 
as internal controls in reporter assays. Moreover, in vivo GFP reporter vectors can be 
used for the investigation of transcriptional activities of cloned regions by fluorescence 
activated cell sorting (FACS) analysis. FACS is a very sensitive system that the reporter 
expression properties of lymphocytes at distinct stages can be comparably observed. 
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Due to cell specific and temporal expression of IL-7R during the development of 
B- and T-lymphocytes, the strategy presented here can be expanded for other cell lines. 
Different regulatory sequences may be activated in lymphocytes at different stages. 
Therefore, activation capabilities of conserved regions can be investigated in several 
cell lines which represent the distinct developmental stages. Double negative, double 
positive, activated or memory single positive cells should be investigated in order to 
evaluate the possible IL-7R activation derived by the cloned conserved noncoding 
sequences.  
 
Although several cellular mechanisms involving cytokines have been uncovered, 
IL-7 signalling will remain as a popular topic for scientists because, many molecular 
mechanisms still remain to be established. Moreover, numerous studies are being 
performed on the possible use of IL-7 on clinical applications (Alpdogan and van den 
Brink, 2005). As IL-7/IL-7R signals are the major components of survival, proliferation 
and peripheral homeostasis of T-lymphocytes, studies on diseases such as AIDS, 
lymphopenia and lymphomas, will increasingly be concentrated on IL-7 signalling. 
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APPENDIX A 
CHEMICALS 
 
 
Name of the chemical Supplier 
6X Loading Dye Fermentas, Germany 
Acetic Acid Riedel-de Haén, Germany 
Agarose low EO Applichem, Germany 
Ampicillin Sigma, Germany 
Boric Acid Riedel-de Haén, Germany 
Bradford Reagent Sigma, Germany 
Calcium Chloride  Merck, Germany 
Chloramphenicol Sigma, Germany 
Dimethylsulfoxide (DMSO)  Sigma, Germany 
Distilled water Milipore, France 
Dulbecco’s Modified Eagle Medium 
(DMEM) 
Sigma, Germany 
Ethylenediaminetetraacetic acid (EDTA) Riedel-de Haén, Germany 
Ethanol Riedel-de Haén, Germany 
Ethidium Bromide Merck, Germany 
Fetal Bovine Serum (FBS) Biological Industries, Israel 
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Glycerol Riedel-de Haén, Germany 
HEPES AppliChem, Germany 
Hydrochloric Acid  Merck, Germany 
Isopropanol Riedel-de Haén, Germany 
Kanamycin Sigma, Germany 
L-glutamine Merck, Germany 
Liquid nitrogen Karbogaz, Turkey 
Luria Agar Sigma, Germany 
Luria Broth Sigma, Germany 
Magnesium Chloride  Promega, USA 
Na2HPO4 AppliChem, Germany 
NaH2PO4 Merck, Germany 
PEG-4000 AppliChem, Germany 
Penicillin-Streptomycin Biological Industries, Israel 
Potassium Chloride  Fluka, Germany 
RPMI 1640 Biological Industries, Israel 
Sodium Chloride Riedel-de Haén, Germany 
Sodium Hydroxide Merck, Germany 
Triton X-100 Promega, USA 
Tris Fluka, Switzerland 
Trypan Blue Sigma, Germnay 
Trypsin-EDTA Biological Industries, Israel 
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APPENDIX B 
MOLECULAR BIOLOGY KITS 
 
 
 
Luciferase Assay System      Promega, USA 
QIAGEN Plasmid Midi Kit      Qiagen, Germany 
Qiaprep Spin Miniprep Kit      Qiagen, Germany  
Qiaquick Gel Extraction Kit      Qiagen, Germany 
Qiaquick PCR Purification Kit     Qiagen, Germany 
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APPENDIX C 
EQUIPMENT 
 
 
 
Name of the equipment Supplier 
Autoclave Certoclav, Table Top Autoclave CV-EL-12L, Austria 
Hirayama, Hiclave HV-110, Japan 
Automatic pipette Pipetus Akku, Hirshmann Laborgerate, Germany 
Balance Sartorius, BP221S, Germany 
Schimadzu, Libror EB-3200 HU, Japan 
Black 96-well Plates Cole Palmer 
Cell counter Cole Palmer, USA 
Cell culture disposables Trp, Switzerland 
Centrifuge Eppendorf, 5415D, Germany 
Hitachi, Sorvall RC5C Plus, USA 
CO2 incubator Binder,CO2 incubator, Germany 
Deep Freeze -80°C, Thermo Electron Corp.,Forma -86ULT Freezer 
USA 
-20°C, Bosch, Turkey 
Distilled Water Millipore, Elix-S, France 
Electrophoresis Biogen Inc., USA 
Biorad Inc., USA 
Electroporation cuvettes Cole Palmer, USA 
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Electroporator BTX ElectroCell Manipulator, ECM 630,  
Division of Genetronics, USA 
Filter membranes Millipore, USA 
Flourescent Microscope Olympus BX 60, Japan 
Olympus IX 70, Japan 
Gel Documentation UVITEC, UVdoc Gel Documentation System, UK 
Hematocytometer Hausser Scientific, Blue Bell Pa., USA 
Ice Machine Scotsman Inc., AF20, USA 
Incubator  Memmert, Modell 300, Germany 
Memmert, Modell 600, Germany 
Laminar Hood Kendro Lab. Prod., Heraeus, HeraSafe HS12, Germany 
Luminometer SpectraMax Gemini XS Dual-Scanning Microplate 
Spectrofluorometer 
Molecular Devices Inc., USA 
Microliter Pipette Eppendorf, Germany 
Microscopes Olympus CH20, Japan 
Olympus CK40, Japan 
Microwave Oven Bosch, Turkey 
pH Meter WTW, pH540 GLP MultiCal, Germany 
Power Supply Biorad, PowerPac 300, USA 
Refrigerator +4°C, Bosch, Turkey 
Shaker New Brunswick Sci., Innova 4330, USA 
Spectrophotometer Schimadzu, UV-1208, Japan 
Schimadzu, UV-3150, Japan 
Thermocycler Eppendorf, Mastercycler Gradient, Germany 
Thermomixer Thermomixer Comfort Eppendorf, Germany 
UV Illuminator BioRAD UV-Transulliminator 2000, USA 
Vortex Velp Scientifica, Italy 
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APPENDIX D 
ENZYMES AND REACTION BUFFERS 
 
 
Name of the Enzyme or Buffer Company 
BamH I Promega, USA 
Buffer B Promega, USA 
Buffer D Promega, USA 
Buffer E Promega, USA 
Buffer E Promega, USA 
Buffer K Promega, USA 
Calf Intestinal Alkaline Phosphatase (CIAP) Promega, USA 
DNA Polymerase I Large (Klenow) 
Fragment Promega, USA 
Hind III Promega, USA 
Klenow Enzyme Buffer Promega, USA 
Nco I Promega, USA 
Pvu II Promega, USA 
Recombinant Luciferase Promega, USA 
Sal I Promega, USA 
Sma I Fermentas, Germany 
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Sph I Promega, USA 
T4 DNA Ligase Promega, USA 
T4 DNA LigaseBuffer Promega, USA 
Tango Buffer  Fermentas, Germany 
Taq DNA Polymerase Promega, USA 
Taq DNA Polymerase Buffer Promega, USA 
Xba I Promega, USA 
Xho I Promega, USA 
Xmn I Promega, USA 
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APPENDIX E 
Plasmids, cells, oligonucleotides and molecular weight markers 
 
 
Item Supplier 
∆56fosCAT NCI, USA 
293T cell line NCI, USA 
BAC Clone (RP23-365P6) Children’s Hospital Oakland Research 
Institute, USA 
E.coli DH5α Sabancı University Biolab-1 
EL-4 cell line NCI, USA 
Gene Ruler 1 kb DNA Ladder Fermentas, Germany 
Gene Ruler 100 bp DNA Ladder Fermentas, Germany 
Mass Ruler DNA Ladder High Range Fermentas, Germany 
Mass Ruler DNA Ladder Low Range Fermentas, Germany 
Mass Ruler DNA Ladder Mix Fermentas, Germany 
pGL3 Basic Promega, USA 
pGL3 Control Promega, USA 
pGL3 Enhancer Promega, USA 
pGL3fos Constructed in lab 
pGL3fos Kpl 7-13 vectors Constructed in lab 
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pmaxGFP Amaxa Biosystems, Israel 
Primers Operon Biotechnologies Inc., USA 
 
 
 
Primers: 
 
Kpl 7 
Forward 
Primer: GACGCGTCGACGGCTCCAAAGCTAACCAAAA 
 
Reverse 
Primer: GACGCGTCGACGAACGTGGTCCTCTCACACA 
Kpl 8  
Forward 
Primer: GACGCGTCGACTCGTAAACCTATCGTCTGTTGG 
 
Reverse 
Primer: GACGCGTCGACAGACCCAATAGTTTGCACTGAA 
Kpl 9 
Forward 
Primer: GACGCGTCGACACATTCCTCACAGGGAAGCA 
 
Reverse 
Primer: GACGCGTCGACGCTGATCGAATGCAAAATGA 
Kpl 
10 
Forward 
Primer: GACGCGTCGACCCTTCCCCCTCCAGATATAAA 
 
Reverse 
Primer: GACGCGTCGACCTAATCCCGGGTCCAAATCT 
Kpl 
11 
Forward 
Primer: GACGCGTCGACCCAAGGAATAAACCCAAGGA 
 
Reverse 
Primer: GACGCGTCGACTCTCCCAAGCAACAAAAGAA 
Kpl 
12 
Forward 
Primer: GACGCGTCGACATAGTGCAGCCTTGCCTCTC 
 
Reverse 
Primer: GACGCGTCGACAGAAGCACGCTTGTATGTGC 
Kpl 
13 
Forward 
Primer: GACGCGTCGACAAAATCACCCACACTGTTGAAA 
 
Reverse 
Primer: GACGCGTCGACCCAAGACGTTGTTCCTCCAG 
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DNA molecular weight markers: 
 
Gene Ruler 100 bp  Gene Ruler 1 kb    
DNA Ladder   DNA Ladder   
        
 
      
 
 
 
 
Mass Ruler   Mass Ruler   Mass Ruler 
DNA Ladder   DNA Ladder   DNA Ladder 
Low Range   High Range   Mix 
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APPENDIX F 
Schematic map of ∆56fosCAT vector 
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Vector map of pGL3 Basic 
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Vector map of pGL3 Enhancer 
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pGL3 Vectors multiple cloning regions: 
 
 
 
Vector map of pGL3fos 
 
pGL3fos
4996 bp
luc+Amp(R)
sv 40 Late PolyA Signal
Synthetic poly(A) signal
fos Promoter
f1 ori
COLE1 ORI
SalI (2189)
HindIII (54)
NcoI (265)
PvuII (99)
Sph I (930)
BamHI (2183)
KpnI (6)
Sac I (12)
XhoI (33)
XmnI (3931)
Not I (4830)
Sma I (29)
XbaI (228)
XbaI (1921)
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Vector map of pGL3fos Enhancer 
 
 
pGL3fos Enhancer
5242 bp
Amp(R)
luc+
SV40 Enhancer
Synthetic poly(A) signal
SV40 Late Poly(A) Signal
fos Promoter
f1 ori
COLE1 ORI
BamHI (2429)
HindIII (54)
NcoI (265)
Pvu II (99)
SalI (2435)
XbaI (228)
XbaI (1921)
Sph I (930)
Sph I (2287)
Sph I (2359)
 
 
 
Vector map of pGL3fos Kpl 7 
 
 
pGL3fos-Kpl7
5432 bp
luc+
Amp(R)
Kpl 7
Synthetic poly(A) signal
sv 40 Late PolyA
fos Promoterf1 ori
COLE1 ORI
PvuII (99)
PvuII (2518)
SalI (2189)
SalI (2625)
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Vector map of pGL3fos Kpl 8 
 
 
pGL3fos-Kpl8
5569 bp
luc+
Amp(R)
Kpl8
sv 40 Late PolyA
Synthetic poly(A) signal fos Promoter
f1 ori
COLE1 ORI
SalI (2189)
SalI (2762)
XmnI (2508)
XmnI (2592)
XmnI (4504)
 
 
 
Vector map of pGL3fos Kpl 9 
 
 
pGL3fos-Kpl9
5836 bp
luc+
Amp(R)
Kpl9
sv 40 Late PolyA
Synthetic poly(A) signal fos Promoter
f1 ori
COLE1 ORI
SalI (2189)
SalI (3029)
XbaI (228)
XbaI (1921)
XbaI (2638)
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Vector map of pGL3fos Kpl 10 
 
 
pGL3fos-Kpl10
6240 bp
luc+
Amp(R)
Kpl10
sv40 Late PolyA
Synthetic poly(A) signal
fos Promoterf1 ori
COLE1 ORI
SalI (2189)
SalI (3433)
SmaI (29)
SmaI (3424)
 
 
 
Vector map of pGL3fos Kpl 11 
 
 
pGL3fos-Kpl11
5757 bp
luc+
Amp(R)
Kpl11
sv 40 Late PolyA
Synthetic poly(A) signal fos Promoter
f1 ori
COLE1 ORI
NcoI (265)
NcoI (2694)
SalI (2189)
SalI (2950)
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Vector map of pGL3fos Kpl 12 
 
 
pGL3fos-Kpl12
5494 bp
luc+
Amp(R)
Kpl 12
sv 40 Late PolyA
Synthetic poly(A) signal fos Promoter
f1 ori
COLE1 ORI
SalI (2189)
SalI (2687)
 
 
 
Vector map of pGL3fos Kpl 13 
 
 
pGL3fos-Kpl13
5543 bp
luc+
Amp(R)
Kpl 13
sv 40 Late PolyA
Synthetic poly(A) signal
fos Promoterf1 ori
COLE1 ORI
HindIII (54)
HindIII (2605)
SalI (2189)
SalI (2736)
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Vector map of pmaxGFP 
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APPENDIX G 
Sequences Amplified and/or cloned DNA fragments 
 
(in FASTA format) 
 
> fos promoter 
TCGAGGTCCATCCATTCACAGCGCTTCTATAAAGGCGCCAGCTGAGGCGCCT
ACTACTCCAACCGCGACTGCAGCGAGCAACTGAGAAGACTGGATAGAGCCG
GCGGTTCCGCGAACGAGCAGTGACCGCGCTCCCACCCAGCTCTGCTCTGCA
GCTCCCACCAGTGTCTCTAG 
 
>Kpl 7 
GGCTCCAAAGCTAACCAAAATGTCAGAGACGTTTATTCACGTCATCAAACC
TCACCCTCTCAACAAATTTAACTTTATATCCTATCTTCAAGGCATCTCAAAC
CAGCTGGTCAGCTCCCTGCACCTAAGTCAACTTAGTAGCTTTTACTTTTCCA
GAAGGCCCACTACTGCACATTTAACAGTGGATTTATGGTCATAATTCAAACC
ATGGGACTGCGTAGAAGGGTTTGAAAGTTTCCAATGGCACTGACTCACTGT
CTGCCTTACCAAGTGTGCCCTGTCAAATAAACCCTCATTGATGTCACTGCAT
TCTCATAACCCCAAAAACTAAGATTCAGAGCTGGGAAATGGTTCCACTTGC
ACCACATCTCTTAGACTGGTGCACAATGGTGTAATGGCATTGGTAATAATGT
GTGAGAGGACCACGTTC 
 
>Kpl 8 
TCGTAAACCTATCGTCTGTTGGTAGAACCTTCTTCAGTGCCTCTTCTCACCTT
TCCTCCCCCACCCATTTCGGAAGAAACACACATCCCTAGCACTACACATCTG
CCTCACACTGTGGGGCAGAAGGTGGGACAGATTACCAAAGTACATGAGATG
CATACATAATGTGAAAGTTTTATCTTCAGCCCTCAGAGTTAAGAAGTATTAT
TTCTTCCTCCTTACTGCTACATACACAGTTGAAAGGGCTTTTGTTCCAATCCT
CAAAGTTAAGAAGCATTATTTCTTCCTCCTCACTACTTACCCACATCTGAAC
ACATTCAGAGAGACACCTAAAATACACATATATCAGATCAACTAAGAAAAA
AAAATATGGCCACACTTGCATTTTGCTTTGAAGATTTTCTGATAATATCAAA
GATCATTTCCATAACCACAGTCCTAGTTTCACAGTCCAGGGAAAGTTTTTTA
ACCACTTCAGGAATATAACTAAATACAATTTTCTTGAGCTTTCTCTGTGCTA
CATTAGGCACAGACTTTAGCTAGGTTTCAGTGCAAACTATTGGGTCT 
 
>Kpl 9 
ACATTCCTCACAGGGAAGCAATACACAGACTGCACTGCCTTCTGTCCTGTGT
GTTCTTACCCACCAGGAACTGCTCCATTCTCTCTGACTAGGATTCTTTTACTC
TACACGCAACACTTCCACATTTTTTCCTTTGAAAGAAATTGCTCATGATTCC
 99 
AGCAATGGTGGTTCTGGCTACTGTTGACATGCATGAGTAATTTGTATTGTAA
TCGCTTCTTCAGTGGCTTTATAAACAAACATTTCTTGTGATCACAAAAGTAT
CTACCTAGAAAGTTGAGGGGAAAGGGTAATTGGTTTCTGTTTTCAATGTGAA
TCAGAGAAGGACTGAAAGTGGTGTTTTGGGACTGCTTGAAGAAGTGAGAGA
GGCTCTTCAAGCTGATGGGGCGCCTGTGGCAAGCATGAAATATAGATTCCA
AATTCCTTTTCAGTTGCTTCAACTCACTTCTAGAAATTCACTTTTCCAAATGA
TGAAATTTTAATTCCCAATAACTGTCACTTTAAACATGGTGGAAAATGCACT
TGGATTGCATATTTCAGCTCATTTGCAAATGTGACAAACAGGAGTGAATTAA
TATGTTGATGACCAAAAAGGAGAATAAGATTCTGAGCAACAGTGAAACAAA
AGCAATAAGAACTCAAGGGGAAAAATAAAAACAATACTAAAGTTCCAAGA
AATTGGCAATAAAAACATTTAAAACTCTCATTTTGCTGAAAGAGAGACAAA
TAAAAACTGATATAAAAAGAAAAGCTATATGTAAGAAATATTCATCTTACC
CCCCTACAAAGCACAGATGTAAATGCAGATACAGAGAATTCATTTTGCATT
CGATCAGC 
 
>Kpl 10 
CCTTCCCCCTCCAGATATAAACAGTGATGACTACCTTTATGCTTCATGACCT
ATATACTCACATCACTACTACATGTATGGTTCTTTGCTACATGTGTAACACA
TGCAAAAGGTGTTTGCTTCCCCATCAACCTGCCCATCATCTTTTCTCGTGTTC
TTCCTTTTGCTAATACATCTCTAGCTTTAGTTGGGTTCACATTTCTCTTCTTCA
TTTGAAACTAAAGTAACCATAACAACTATTTTTTCTGACCAATATGTTTCAA
GAAAAAAAATTAATCTCCAGAGAACACCTGGGTCGCAATATCCCTGCGAGA
GTGGTGGCAAATAGCTGAAGTCCCTCAGAAAGTGCCTTATAGGACTATGGG
GAGGGATGAAGGCAGAACACAGGCTCATCAGGCCTGTGTCAGAGCACAGA
CAGAAGCAGTCTCTTAGCTGGCCTTTTCCTCAAACTACTCTGGGTGCTTTTCC
TGACTAGGGCATCACCACTGTAGTGGAAGGGATATTCATGCCTGCTTCTGAT
TCCTACCAGGGCATTATGAGCTTCCTTTCCTGAAAGCCTCTTGCTTTCTCTAA
GAACTCTTCCTCTTGTTAGCAGTTTAATCAAAATTTGAATTGAACCTGACGC
TAAAATACTCACTTGCTTATAGAAATGTCTTTAACAAGGAGTAAACCACCA
GAACTCACAGACTCTGTCTGGCATACCCAAAGATACAGTCAGAAATCTTAT
GGAGGCTTTGGAGGCATAATACTACAGTATTTCATATTACACCTAGAAAGA
AGAGAAAGAAAAAGAAGCAGAAAGAAGAAGACACACAACTGAAGATGTAT
GGTAAGGAGAAAAGAGAAATGTAAGAAGAGTCACAAAAGGAAAAGGTTGT
ACTCCTAGAAATGAAACTTCAAAATGCTGGGGCTCCCCCTCAGAGCCCTTG
GACTGAGTCAGCACAACTCATAAAGTGCTAAGACAATGCTGTTCAGTTGGA
GTTGAAGTACATGGGTTCCTTTAACCACCCTCGCCTACCTGATCCCCATGAG
AGTTTTCACCTCACTTACCACCTGCTCTGCTAAGCAGATGTAATTATCTTCCC
AGAAGAAAGCAGGTGCCCAGGCTTCTTTCATATCTTAACTACAGAATCTACT
GACTAAGGCAGGTAGAGGGGTGCAGTTAGTACAGACCTGATGGAATGCATT
TGAATACATTTTAAGTATTCCTGGGACATGAGATTTGGACCCGGGATTAG 
 
>Kpl 11 
CCAAGGAATAAACCCAAGGACCTTCCCTTGGGTCCTGGCTTCTCAGGTGCCC
AAAGACTCTTTTTTCATCTTCCTTTCAAACAACTCTGACAAAGCAGTGCCAT
CCATGTCTGTCATGTGGAGGTCAGGGAGGACAGATAAGAAAAGGGAAGTTC
TTTGCCTGCTTTCGGCTTCAAAGGATCCTACGTTAAGAAACAGAGTTACCAT
TGCTCACCCACAATCTCTAGAAGTATTAGTGATGTTTCTCATTTTTCTTTAAG
CTTCCCGCACTCTATTTAGATTTCTCTCTGATGTCCTTTCAGCATCTCCTGCC
CCACCCAAAAGGGGTAAGCACACCAGTGGAAATCCCCTGAGCAAACTAGCA
CATGCTGTACCAAAATATTATGTCTTAACTTTGTTCTTTTACATCTTCACAAC
 100 
TAAAGGAAAGAGATACAATCAAAATGATGGTCCACTTAAATGATAAACAAG
AGAATTTAAAGAGACATGATACAATTGTTCACCATGGAGTGATAGCCCATG
AAAGGCTGATGAGGTTGGGGTTAGTAGATATAATACATATGAATTTCTCCTT
AAACATTTTCACATAGCTTTGAGAATTTATCATTGTAGATTTCTAGAAAGCA
CATTCAACTTAGTGTGCAAAACAGGCTGATTTTGCGGTATGTTTTTCTGATG
AAGCTTTCAAAGCAAGATTACAAGCCAGAGTGTAAATAATTACCTGATTCC
CCAAATCATTTCTTTTGTTGCTTGGGAGA 
 
>Kpl 12 
ATAGTGCAGCCTTGCCTCTCATTAGAGAAGCTCTTTTCTCACTTCTCTCTCAG
AGAGCAGAGAACTGGGCGTGACCATTGAGGGTTCAGCCCTAAGTGGGACAA
CTCTATCCTAGCATCATTATTCCTAAAACAAGAGCATCCCCAACCAACTGAG
GAGCATCGTAAGTGTGGATTTTGGCCTTGTGATCCTGTTACATTGGACCCTG
AGATCATCTGAAGCATCACTTGAAGTCTACCACCTTGCTCAAAAGTAAGCA
GTTAAGTTCAGGAGCTTCAGGGAATACCAAGATGCAGGAAAAAAAAAAGT
CACACTCTACCTCTCCGTTTTCTCTACCTCTGCTTACAGCAGCAATCCTTTTG
CTCAGACTTCCTGTTTCTGGCACTTGCCTTCTTCTGTGATGTTCATAGTTCCC
TGTCTGTGGTTTAGCAGGCACAGAGCTGGTTTGGGTCTCCCTCTCTCTCATTC
ACTTGCACATACAAGCGTGCTTCT 
 
>Kpl 13 
AATCACCCACACTGTTGAAACAGTTGAATTCCAGACTATCTAGTCAATGGA
AAATTTCCAGTAATCTATAGGACCAAGTTGATTCTTGTTTTCATATGGCCCT
GGAGGAAATCAAAGTGCAAAGAAAGCTTTAGGTCTGAAGGTTGATAAAGA
ACTCAGGGAGTTGTATCTTCTTCCTCCCCCACCAGCCATCGCTTGTTGCCAA
GGGTTATTATCTCTGGTGACTTGAAGAAAAAATACTCTAATATGAAATTCTG
GCTTGTGGCTATTTCCAAATTCATATCAGATGACCTCATTTTTTGGTAAGTTT
CCATATAAGGAAAGTATGTCGAGGTCTGCAGTAGTAAAAGAGGACTTCTGA
AGTTCCATGAGCGCTAAGGAAATCCTTTGCCGCCTACAACCCAGATAAGCT
GTAGATTCTCACTCTTCTGAATCTCTAGCAGTTTCCTGAAGCTATACACAAA
GTTTTCCTGAAGTCACTGGAGGAACAACGTCTTGGAGTTGAATGTCACAGA
ATACCCTCAGTCTGTCTTTGTTATTG 
 
 
